Financial instruments |
35 Financial instruments The disclosure of the Group’s financial instruments below includes the following sections: – Concentration of credit risk; – Fair value measurement (including fair value hierarchy, transfers between levels; level 3 reconciliation; qualitative and quantitative disclosures of valuation techniques and nonrecurring fair value changes); – Disclosures about fair value of financial instruments not carried at fair value. Concentrations of credit risk Credit risk concentrations arise when a number of counterparties are engaged in similar business activities, are located in the same geographic region or when there are similar economic features that would cause their ability to meet contractual obligations to be similarly impacted by changes in economic conditions. The Group regularly monitors the credit risk portfolio by counterparty, industry, country and product to ensure that such potential concentrations are identified, using a comprehensive range of quantitative tools and metrics. Credit limits relating to counterparties and products are managed through counterparty limits which set the maximum credit exposures the Group is willing to assume to specific counterparties over specified periods. Country limits are established to avoid any undue country risk concentration. From an industry point of view, the combined credit exposure of the Group is diversified. A large portion of the credit exposure is with individual clients, particularly through residential mortgages in Switzerland, or relates to transactions with financial institutions. In both cases, the customer base is extensive and the number and variety of transactions are broad. For transactions with financial institutions, the business is also geographically diverse, with operations focused in the Americas, Europe and, to a lesser extent, Asia Pacific. A significant portion of the Group’s financial instruments is carried at fair value. Deterioration of financial markets could significantly impact the fair value of these financial instruments and the results of operations. The fair value of the majority of the Group’s financial instruments is based on quoted prices in active markets or observable inputs. These instruments include government and agency securities, certain CP, most investment grade corporate debt, certain high yield debt securities, exchange-traded and certain OTC derivatives and most listed equity securities. In addition, the Group holds financial instruments for which no prices are available and which have few or no observable inputs. For these instruments, the determination of fair value requires subjective assessment and judgment, depending on liquidity, pricing assumptions, the current economic and competitive environment and the risks affecting the specific instrument. In such circumstances, valuation is determined based on management’s own judgments about the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk. These instruments include certain OTC derivatives, including interest rate, foreign exchange, equity and credit derivatives, certain corporate equity-linked securities, mortgage-related and CDO securities, private equity investments and certain loans and credit products, including leveraged finance, certain syndicated loans and certain high yield bonds, and life finance instruments. The fair value measurement disclosures exclude derivative transactions that are daily settled. The fair value of financial instruments is impacted by factors such as benchmark interest rates, prices of financial instruments issued by third parties, commodity prices, foreign exchange rates and index prices or rates. In addition, valuation adjustments are an integral part of the valuation process when market prices are not indicative of the credit quality of a counterparty, and are applied to both OTC derivatives and debt instruments. The impact of changes in a counterparty’s credit spreads (known as credit valuation adjustments) is considered when measuring the fair value of assets, and the impact of changes in the Group’s own credit spreads (known as debit valuation adjustments) is considered when measuring the fair value of its liabilities. For OTC derivatives, the impact of changes in both the Group’s and the counterparty’s credit standing is considered when measuring their fair value, based on current CDS prices. The adjustments also take into account contractual factors designed to reduce the Group’s credit exposure to a counterparty, such as collateral held and master netting agreements. For hybrid debt instruments with embedded derivative features, the impact of changes in the Group’s credit standing is considered when measuring their fair value, based on current funded debt spreads. US GAAP permits a reporting entity to measure the fair value of a group of financial assets and financial liabilities on the basis of the price that would be received to sell a net long position or paid to transfer a net short position for a particular risk exposure in an orderly transaction between market participants at the measurement date. As such, the Group continues to apply bid and offer adjustments to net portfolios of cash securities and/or derivative instruments to adjust the value of the net position from a mid-market price to the appropriate bid or offer level that would be realized under normal market conditions for the net long or net short position for a specific market risk. In addition, the Group reflects the net exposure to credit risk for its derivative instruments where the Group has legally enforceable agreements with its counterparties that mitigate credit risk exposure in the event of default. Valuation adjustments are recorded in a reasonable and consistent manner that results in an allocation to the relevant disclosures in the notes to the financial statements as if the valuation adjustment had been allocated to the individual unit of account. Fair value hierarchy The levels of the fair value hierarchy are defined as follows: – Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Group has the ability to access. This level of the fair value hierarchy provides the most reliable evidence of fair value and is used to measure fair value whenever available. – Level 2 : Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly. These inputs include: (i) quoted prices for similar assets or liabilities in active markets; (ii) quoted prices for identical or similar assets or liabilities in markets that are not active, that is, markets in which there are few transactions for the asset or liability, the prices are not current or price quotations vary substantially either over time or among market makers, or in which little information is publicly available; (iii) inputs other than quoted prices that are observable for the asset or liability; or (iv) inputs that are derived principally from or corroborated by observable market data by correlation or other means. – Level 3: Inputs that are unobservable for the asset or liability. These inputs reflect the Group’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). These inputs are developed based on the best information available in the circumstances, which include the Group’s own data. The Group’s own data used to develop unobservable inputs is adjusted if information indicates that market participants would use different assumptions. The Group records net open positions at bid prices if long, or at ask prices if short, unless the Group is a market maker in such positions, in which case mid-pricing is utilized. Fair value measurements are not adjusted for transaction costs. Qualitative disclosures of valuation techniques The following information on the valuation techniques and significant unobservable inputs of the various financial instruments and the section “Uncertainty of fair value measurements at the reporting date from the use of significant unobservable inputs” should be read in conjunction with the tables “Assets and liabilities measured at fair value on a recurring basis”, “Quantitative information about level 3 assets at fair value” and “Quantitative information about level 3 liabilities at fair value”. Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions Securities purchased under resale agreements and securities sold under repurchase agreements are measured at fair value using discounted cash flow analysis. Future cash flows are discounted using observable market interest rate repurchase/resale curves for the applicable maturity and underlying collateral of the instruments. As such, the significant majority of both securities purchased under resale agreements and securities sold under repurchase agreements are included in level 2 of the fair value hierarchy. Structured resale and repurchase agreements include embedded derivatives, which are measured using the same techniques as described below for stand-alone derivative contracts held for trading purposes or used in hedge accounting relationships. If the value of the embedded derivative is determined using significant unobservable inputs, those structured resale and repurchase agreements included are classified as level 3 in the fair value hierarchy. The significant unobservable input is funding spread. Securities purchased under resale agreements are usually fully collateralized or over-collateralized by government securities, money market instruments, corporate bonds, or other debt instruments. In the event of counterparty default, the collateral service agreement provides the Group with the right to liquidate the collateral held. Debt securities Foreign governments Foreign government debt securities typically have quoted prices in active markets and are mainly categorized as level 1 instruments. Valuations of foreign government debt securities for which market prices are not available are based on yields reflecting credit rating, historical performance, delinquencies, loss severity, the maturity of the security, recent transactions in the market or other modeling techniques, which may involve judgment. Those securities where the price or model inputs are observable in the market are categorized as level 2 instruments, while those securities where prices are not observable and significant model inputs are unobservable are categorized as level 3 of the fair value hierarchy. Corporates Corporate bonds are priced to reflect current market levels either through recent market transactions or broker or dealer quotes. Where a market price for the particular security is not directly available, valuations are obtained based on yields reflected by other instruments in the specific or similar entity’s capital structure and adjusting for differences in seniority and maturity, benchmarking to a comparable security where market data is available (taking into consideration differences in credit, liquidity and maturity), or through the application of cash flow modeling techniques utilizing observable inputs, such as current interest rate curves and observable CDS spreads. Significant unobservable inputs may include correlation and price. For securities using market comparable price, the differentiation between level 2 and level 3 is based upon the relative significance of any yield adjustments as well as the accuracy of the comparison characteristics (i.e., the observable comparable security may be in the same country but a different industry and may have a different seniority level – the lower the comparability the more likely the security will be level 3). RMBS, CMBS and CDO securities Fair values of RMBS, CMBS and CDO may be available through quoted prices, which are often based on the prices at which similarly structured and collateralized securities trade between dealers and to and from customers. Fair values of RMBS, CMBS and CDO for which there are significant unobservable inputs are valued using capitalization rate and discount rate. Price may not be observable for fair value measurement purposes for many reasons, such as the length of time since the last executed transaction for the related security, use of a price from a similar instrument, or use of a price from an indicative quote. Fair values determined by market comparable price may include discounted cash flow models using the inputs credit spread, default rate, discount rate, prepayment rate and loss severity. Prices from similar observable instruments are used to calculate implied inputs which are then used to value unobservable instruments using discounted cash flow. The discounted cash flow price is then compared to the unobservable prices and assessed for reasonableness. For most structured debt securities, determination of fair value requires subjective assessment depending on liquidity, ownership concentration, and the current economic and competitive environment. Valuation is determined based on the Front Office’s own assumptions about how market participants would price the asset. Collateralized bond and loan obligations are split into various structured tranches and each tranche is valued based upon its individual rating and the underlying collateral supporting the structure. Valuation models are used to value both cash and synthetic CDOs. Equity securities The majority of the Group’s positions in equity securities are traded on public stock exchanges for which quoted prices are readily and regularly available and are therefore categorized as level 1 instruments. Level 2 and level 3 equities include fund-linked products, convertible bonds or equity securities with restrictions that are not traded in active markets. Significant unobservable inputs may include earnings before interest, taxes, depreciation and amortization (EBITDA) multiple and market comparable price. Derivatives Derivatives held for trading purposes or used in hedge accounting relationships include both OTC and exchange-traded derivatives. The fair values of exchange-traded derivatives measured using observable exchange prices are included in level 1 of the fair value hierarchy. For exchange-traded derivatives where the volume of trading is low, the observable exchange prices may not be considered executable at the reporting date. These derivatives are valued in the same manner as similar observable OTC derivatives and are included in level 2 of the fair value hierarchy. If the similar OTC derivative used for valuing the exchange-traded derivative is not observable, the exchange-traded derivative is included in level 3 of the fair value hierarchy. The fair values of OTC derivatives are determined on the basis of either industry standard models or internally developed proprietary models. Both model types use various observable and unobservable inputs in order to determine fair value. The inputs include those characteristics of the derivative that have a bearing on the economics of the instrument. The determination of the fair value of many derivatives involves only a limited degree of subjectivity because the required inputs are observable in the marketplace, while more complex derivatives may use unobservable inputs that rely on specific proprietary modeling assumptions. Where observable inputs (prices from exchanges, dealers, brokers or market consensus data providers) are not available, attempts are made to infer values from observable prices through model calibration (spot and forward rates, mean reversion, benchmark interest rate curves and volatility inputs for commonly traded option products). For inputs that cannot be derived from other sources, estimates from historical data may be made. OTC derivatives where the majority of the value is derived from market observable inputs are categorized as level 2 instruments, while those where the majority of the value is derived from unobservable inputs are categorized as level 3 of the fair value hierarchy. The valuation of derivatives includes an adjustment for the cost of funding uncollateralized OTC derivatives. Interest rate derivatives OTC vanilla interest rate products, such as interest rate swaps, swaptions and caps and floors are valued by discounting the anticipated future cash flows. The future cash flows and discounting are derived from market standard yield curves and industry standard volatility inputs. Where applicable, exchange-traded prices are also used to value exchange-traded futures and options and can be used in yield curve construction. For more complex products, inputs include, but are not limited to basis spread, correlation, credit spread, prepayment rate and volatility skew. Foreign exchange derivatives Foreign exchange derivatives include vanilla products such as spot, forward and option contracts where the anticipated discounted future cash flows are determined from foreign exchange forward curves and industry standard optionality modeling techniques. Where applicable, exchange-traded prices are also used for futures and option prices. For more complex products inputs include, but are not limited to, contingent probability, correlation and prepayment rate. Equity and index-related derivatives Equity derivatives include a variety of products ranging from vanilla options and swaps to exotic structures with bespoke payoff profiles. The main inputs in the valuation of equity derivatives may include buyback probability, correlation, gap risk, price and volatility. Generally, the interrelationship between the correlation and volatility is positively correlated. Credit derivatives Credit derivatives include index, single-name and multi-name CDS in addition to more complex structured credit products. Vanilla products are valued using industry standard models and inputs that are generally market observable including credit spread and recovery rate. Complex structured credit derivatives are valued using proprietary models requiring inputs such as correlation, credit spread, funding spread, loss severity, prepayment rate and recovery rate. These inputs are generally implied from available market observable data. Other trading assets Other trading assets primarily include life settlement and premium finance instruments and RMBS loans. Life settlement and premium finance instruments are valued using proprietary models with several inputs. The significant unobservable inputs of the fair value for life settlement and premium finance instruments is the estimate of market implied life expectancy, while for RMBS loans it is market comparable price. For life settlement and premium finance instruments, individual life expectancy rates are typically obtained by multiplying a base mortality curve for the general insured population provided by a professional actuarial organization together with an individual-specific multiplier. Individual-specific multipliers are determined based on data from third-party life expectancy data providers, which examine the insured individual’s medical conditions, family history and other factors to arrive at a life expectancy estimate. For RMBS loans, the use of market comparable price varies depending upon each specific loan. For some loans, similar to unobservable RMBS securities, prices from similar observable instruments are used to calculate implied inputs which are then used to value unobservable instruments using discounted cash flow. The discounted cash flow price is then compared to the unobservable prices and assessed for reasonableness. For other RMBS loans, the loans are categorized by specific characteristics, such as loan-to-value ratio, average account balance, loan type (single or multi-family), lien, seasoning, coupon, FICO score, locality, delinquency status, cash flow velocity, roll rates, loan purpose, occupancy, servicers advance agreement type, modification status, Federal Housing Administration insurance, property value and documentation quality. Loans with unobservable prices are put into consistent buckets which are then compared to market observable comparable prices in order to assess the reasonableness of those unobservable prices. Other investments Private equity funds, hedge funds and equity method investment funds Equity method investment funds principally include equity investments in the form of a) direct investments in third-party hedge funds, private equity funds and funds of funds, b) equity method investments where the Group has the ability to significantly influence the operating and financial policies of the investee, and c) direct investments in non-marketable equity securities. Direct investments in third-party hedge funds, private equity funds and funds of funds are measured at fair value based on their published NAVs as permitted by ASC Topic 820 – Fair Value Measurement. In some cases, NAVs may be adjusted where there is sufficient evidence that the NAV published by the investment manager is not in line with the fund’s observable market data, it is probable that the investment will be sold for an amount other than NAV or other circumstances exist that would require an adjustment to the published NAV. Although rarely adjusted, significant judgment is involved in making any adjustments to the published NAVs. The investments for which the fair value is measured using the NAV practical expedient are not categorized within the fair value hierarchy. Direct investments in non-marketable equity securities consist of both real estate investments and non-real estate investments. Equity-method investments and direct investments in non-marketable equity securities are initially measured at their transaction price, as this is the best estimate of fair value. Thereafter, these investments are individually measured at fair value based upon a number of factors that include any recent rounds of financing involving third-party investors, comparable company transactions, multiple analyses of cash flows or book values, or discounted cash flow analyses. The availability of information used in these modeling techniques is often limited and involves significant judgment in evaluating these different factors over time. As a result, these investments are included in level 3 of the fair value hierarchy. Life finance instruments Life finance instruments include single premium immediate annuities (SPIA) and other premium finance instruments. Life finance instruments are valued in a similar manner as described for life settlement and premium finance instruments under the other trading assets section above. Loans The Group’s loan portfolio which is measured at fair value primarily consists of commercial and industrial loans and loans to financial institutions. Within these categories, loans measured at fair value include commercial loans, real estate loans, corporate loans, leverage finance loans and emerging market loans. Fair value is based on recent transactions and quoted prices, where available. Where recent transactions and quoted prices are not available, fair value may be determined by relative value benchmarking (which includes pricing based upon another position in the same capital structure, other comparable loan issues, generic industry credit spreads, implied credit spreads derived from CDS for the specific borrower, and enterprise valuations) or calculated based on the exit price of the collateral, based on current market conditions. Both the funded and unfunded portion of revolving credit lines on the corporate lending portfolio are valued using a loan pricing model, which requires estimates of significant inputs including credit conversion factors, credit spreads, recovery rates and weighted average life of the loan. Significant unobservable inputs may include credit spread and price. The Group’s other assets and liabilities include mortgage loans held in conjunction with securitization activities and assets and liabilities of VIEs and mortgage securitizations that do not meet the criteria for sale treatment under US GAAP. The fair value of mortgage loans held in conjunction with securitization activities is determined on a whole-loan basis and is consistent with the valuation of RMBS loans discussed in “Other trading assets” above. Whole-loan valuations are calculated based on the exit price reflecting the current market conditions. The fair value of assets and liabilities of VIEs and mortgage securitizations that do not meet the criteria for sale treatment under US GAAP are determined based on the quoted prices for securitized bonds, where available, or on cash flow analyses for securitized bonds, when quoted prices are not available. The fair value of the consolidated financial assets of RMBS and CMBS securitization vehicles, which qualify as collateralized financing entities, are measured on the basis of the more observable fair value of the VIEs’ financial liabilities. Short-term borrowings and long-term debt The Group’s short-term borrowings and long-term debt include structured notes (hybrid financial instruments that are both bifurcatable and non-bifurcatable) and vanilla debt. The fair value of structured notes is based on quoted prices, where available. When quoted prices are not available, fair value is determined by using a discounted cash flow model incorporating the Group’s credit spreads, the value of derivatives embedded in the debt and the residual term of the issuance based on call options. Derivatives structured into the issued debt are valued consistently with the Group’s stand-alone derivative contracts held for trading purposes or used in hedge accounting relationships as discussed above. The fair value of structured debt is heavily influenced by the combined call options and performance of the underlying derivative returns. Significant unobservable inputs for short-term borrowings and long-term debt include buyback probability, correlation, credit spread, gap risk, mean reversion, price, recovery rate and volatility. Generally, the interrelationships between correlation, credit spread, gap risk and volatility inputs are positively correlated. Other liabilities Failed sales These liabilities represent the financing of assets that did not achieve sale accounting treatment under US GAAP. Failed sales are valued in a manner consistent with the related underlying financial instruments. Assets and liabilities measured at fair value on a recurring basis
end of 2018 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Assets
measured
at net
asset value
per share | 2 |
Total | | Assets (CHF million) | Cash and due from banks | | 0 | | 115 | | 0 | | – | | – | | 115 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 0 | | 81,818 | | 0 | | – | | – | | 81,818 | | Securities received as collateral | | 37,962 | | 3,704 | | 30 | | – | | – | | 41,696 | | Trading assets | | 76,124 | | 156,066 | | 8,814 | | (109,927) | | 1,126 | | 132,203 | | of which debt securities | | 23,726 | | 36,321 | | 2,076 | | – | | 12 | | 62,135 | | of which foreign governments | | 23,547 | | 4,542 | | 232 | | – | | – | | 28,321 | | of which corporates | | 66 | | 7,984 | | 1,260 | | – | | 12 | | 9,322 | | of which RMBS | | 0 | | 19,652 | | 269 | | – | | – | | 19,921 | | of which equity securities | | 42,758 | | 2,459 | | 132 | | – | | 1,114 | | 46,463 | | of which derivatives | | 7,999 | | 116,942 | | 3,298 | | (109,927) | | – | | 18,312 | | of which interest rate products | | 3,557 | | 65,823 | | 507 | | – | | – | | – | | of which foreign exchange products | | 25 | | 27,526 | | 258 | | – | | – | | – | | of which equity/index-related products | | 4,415 | | 17,967 | | 1,054 | | – | | – | | – | | of which credit derivatives | | 0 | | 4,739 | | 673 | | – | | – | | – | | of which other derivatives | | 1 | | 633 | | 806 | | – | | – | | – | | of which other trading assets | | 1,641 | | 344 | | 3,308 | | – | | – | | 5,293 | | Investment securities | | 2 | | 2,743 | | 166 | | – | | – | | 2,911 | | Other investments | | 14 | | 7 | | 1,309 | | – | | 1,104 | | 2,434 | | of which life finance instruments | | 0 | | 0 | | 1,067 | | – | | – | | 1,067 | | Loans | | 0 | | 10,549 | | 4,324 | | – | | – | | 14,873 | | of which real estate | | 0 | | 146 | | 515 | | – | | – | | 661 | | of which commercial and industrial loans | | 0 | | 3,976 | | 1,949 | | – | | – | | 5,925 | | of which financial institutions | | 0 | | 4,164 | | 1,391 | | – | | – | | 5,555 | | Other intangible assets (mortgage servicing rights) | | 0 | | 0 | | 163 | | – | | – | | 163 | | Other assets | | 117 | | 5,807 | | 1,543 | | (204) | | – | | 7,263 | | of which loans held-for-sale | | 0 | | 4,238 | | 1,235 | | – | | – | | 5,473 | | Total assets at fair value | | 114,219 | | 260,809 | | 16,349 | | (110,131) | | 2,230 | | 283,476 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis (continued)
end of 2018 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Liabilities
measured
at net
asset value
per share | 2 |
Total | | Liabilities (CHF million) | Due to banks | | 0 | | 406 | | 0 | | – | | – | | 406 | | Customer deposits | | 0 | | 2,839 | | 453 | | – | | – | | 3,292 | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | 0 | | 14,828 | | 0 | | – | | – | | 14,828 | | Obligation to return securities received as collateral | | 37,962 | | 3,704 | | 30 | | – | | – | | 41,696 | | Trading liabilities | | 31,940 | | 123,615 | | 3,589 | | (116,985) | | 10 | | 42,169 | | of which debt securities | | 4,460 | | 3,511 | | 25 | | – | | – | | 7,996 | | of which foreign governments | | 4,328 | | 255 | | 0 | | – | | – | | 4,583 | | of which equity securities | | 18,785 | | 118 | | 37 | | – | | 10 | | 18,950 | | of which derivatives | | 8,695 | | 119,986 | | 3,527 | | (116,985) | | – | | 15,223 | | of which interest rate products | | 3,699 | | 62,649 | | 189 | | – | | – | | – | | of which foreign exchange products | | 32 | | 31,983 | | 160 | | – | | – | | – | | of which equity/index-related products | | 4,961 | | 19,590 | | 1,500 | | – | | – | | – | | of which credit derivatives | | 0 | | 5,485 | | 1,140 | | – | | – | | – | | Short-term borrowings | | 0 | | 7,284 | | 784 | | – | | – | | 8,068 | | Long-term debt | | 0 | | 51,270 | | 12,665 | | – | | – | | 63,935 | | of which structured notes over one year and up to two years | | 0 | | 7,242 | | 528 | | – | | – | | 7,770 | | of which structured notes over two years | | 0 | | 28,215 | | 11,800 | | – | | – | | 40,015 | | Other liabilities | | 0 | | 7,881 | | 1,341 | | (221) | | – | | 9,001 | | Total liabilities at fair value | | 69,902 | | 211,827 | | 18,862 | | (117,206) | | 10 | | 183,395 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis (continued)
end of 2017 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Assets
measured
at net
asset value
per share | 2 |
Total | | Assets (CHF million) | Cash and due from banks | | 0 | | 212 | | 0 | | – | | – | | 212 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 0 | | 77,498 | | 0 | | – | | – | | 77,498 | | Securities received as collateral | | 36,697 | | 1,331 | | 46 | | – | | – | | 38,074 | | of which debt securities | | 576 | | 802 | | 0 | | – | | – | | 1,378 | | of which corporates | | 0 | | 726 | | 0 | | – | | – | | 726 | | of which equity securities | | 36,121 | | 529 | | 46 | | – | | – | | 36,696 | | Trading assets | | 87,352 | | 187,767 | | 8,754 | | (128,592) | | 1,053 | | 156,334 | | of which debt securities | | 29,828 | | 40,645 | | 2,292 | | – | | – | | 72,765 | | of which foreign governments | | 29,561 | | 4,256 | | 270 | | – | | – | | 34,087 | | of which corporates | | 179 | | 10,231 | | 1,412 | | – | | – | | 11,822 | | of which RMBS | | 0 | | 21,399 | | 320 | | – | | – | | 21,719 | | of which CMBS | | 0 | | 2,501 | | 16 | | – | | – | | 2,517 | | of which CDO | | 0 | | 2,255 | | 126 | | – | | – | | 2,381 | | of which equity securities | | 51,025 | | 3,481 | | 163 | | – | | 1,053 | | 55,722 | | of which derivatives | | 3,577 | | 141,347 | | 3,289 | | (128,592) | | – | | 19,621 | | of which interest rate products | | 1,219 | | 84,932 | | 801 | | – | | – | | – | | of which foreign exchange products | | 19 | | 30,302 | | 188 | | – | | – | | – | | of which equity/index-related products | | 2,338 | | 18,251 | | 833 | | – | | – | | – | | of which credit derivatives | | 0 | | 7,107 | | 634 | | – | | – | | – | | of which other trading assets | | 2,922 | | 2,294 | | 3,010 | | – | | – | | 8,226 | | Investment securities | | 250 | | 1,899 | | 42 | | – | | – | | 2,191 | | of which debt securities | | 244 | | 1,780 | | 42 | | – | | – | | 2,066 | | of which foreign governments | | 97 | | 1,139 | | 0 | | – | | – | | 1,236 | | of which corporates | | 0 | | 238 | | 0 | | – | | – | | 238 | | of which RMBS | | 0 | | 167 | | 40 | | – | | – | | 207 | | of which CMBS | | 0 | | 171 | | 2 | | – | | – | | 173 | | of which equity securities | | 6 | | 119 | | 0 | | – | | – | | 125 | | Other investments | | 25 | | 16 | | 1,601 | | – | | 1,864 | | 3,506 | | of which private equity | | 0 | | 0 | | 29 | | – | | 351 | | 380 | | of which equity funds | | 0 | | 0 | | 22 | | – | | 141 | | 163 | | of which hedge funds | | 0 | | 0 | | 0 | | – | | 391 | | 391 | | of which debt funds | | 0 | | 0 | | 0 | | – | | 239 | | 239 | | of which other equity investments | | 25 | | 9 | | 271 | | – | | 1,122 | | 1,427 | | of which private | | 18 | | 9 | | 271 | | – | | 1,122 | | 1,420 | | of which life finance instruments | | 0 | | 7 | | 1,301 | | – | | – | | 1,308 | | Loans | | 0 | | 10,777 | | 4,530 | | – | | – | | 15,307 | | of which commercial and industrial loans | | 0 | | 3,437 | | 2,207 | | – | | – | | 5,644 | | of which financial institutions | | 0 | | 4,890 | | 1,480 | | – | | – | | 6,370 | | Other intangible assets (mortgage servicing rights) | | 0 | | 0 | | 158 | | – | | – | | 158 | | Other assets | | 101 | | 7,570 | | 1,511 | | (164) | | – | | 9,018 | | of which loans held-for-sale | | 0 | | 5,800 | | 1,350 | | – | | – | | 7,150 | | Total assets at fair value | | 124,425 | | 287,070 | | 16,642 | | (128,756) | | 2,917 | | 302,298 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis (continued)
end of 2017 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Liabilities
measured
at net
asset value
per share | 2 |
Total | | Liabilities (CHF million) | Due to banks | | 0 | | 197 | | 0 | | – | | – | | 197 | | Customer deposits | | 0 | | 3,056 | | 455 | | – | | – | | 3,511 | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | 0 | | 15,262 | | 0 | | – | | – | | 15,262 | | Obligation to return securities received as collateral | | 36,697 | | 1,331 | | 46 | | – | | – | | 38,074 | | of which debt securities | | 576 | | 802 | | 0 | | – | | – | | 1,378 | | of which corporates | | 0 | | 726 | | 0 | | – | | – | | 726 | | of which equity securities | | 36,121 | | 529 | | 46 | | – | | – | | 36,696 | | Trading liabilities | | 23,108 | | 149,637 | | 3,226 | | (136,861) | | 9 | | 39,119 | | of which debt securities | | 5,160 | | 4,139 | | 2 | | – | | – | | 9,301 | | of which foreign governments | | 5,108 | | 746 | | 0 | | – | | – | | 5,854 | | of which corporates | | 12 | | 3,334 | | 2 | | – | | – | | 3,348 | | of which equity securities | | 14,217 | | 883 | | 55 | | – | | 9 | | 15,164 | | of which derivatives | | 3,731 | | 144,615 | | 3,169 | | (136,861) | | – | | 14,654 | | of which interest rate products | | 1,254 | | 80,534 | | 317 | | – | | – | | – | | of which foreign exchange products | | 8 | | 35,707 | | 100 | | – | | – | | – | | of which equity/index-related products | | 2,468 | | 19,459 | | 1,301 | | – | | – | | – | | of which credit derivatives | | 0 | | 7,982 | | 898 | | – | | – | | – | | Short-term borrowings | | 0 | | 10,174 | | 845 | | – | | – | | 11,019 | | Long-term debt | | 0 | | 51,127 | | 12,501 | | – | | – | | 63,628 | | of which treasury debt over two years | | 0 | | 936 | | 0 | | – | | – | | 936 | | of which structured notes over one year and up to two years | | 0 | | 6,216 | | 149 | | – | | – | | 6,365 | | of which structured notes over two years | | 0 | | 32,782 | | 12,259 | | – | | – | | 45,041 | | of which other debt instruments over two years | | 0 | | 2,221 | | 61 | | – | | – | | 2,282 | | of which other subordinated bonds | | 0 | | 5,567 | | 0 | | – | | – | | 5,567 | | of which non-recourse liabilities | | 0 | | 833 | | 30 | | – | | – | | 863 | | Other liabilities | | 0 | | 7,379 | | 1,478 | | (233) | | – | | 8,624 | | of which failed sales | | 0 | | 439 | | 223 | | – | | – | | 662 | | Total liabilities at fair value | | 59,805 | | 238,163 | | 18,551 | | (137,094) | | 9 | | 179,434 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis for level 3 | | | | | | | | | | | | | | | | |
Trading revenues | |
Other revenues | | Accumulated other
comprehensive income | | | | | |
2018 | |
Balance at
beginning
of period | |
Transfers
in | |
Transfers
out | |
Purchases | |
Sales | |
Issuances | |
Settlements | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | | Foreign
currency
translation
impact | |
Balance
at end
of period | | Assets (CHF million) | Securities received as collateral | | 46 | | 0 | | (15) | | 102 | | (103) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 30 | | Trading assets | | 8,754 | | 1,563 | | (1,602) | | 40,057 | | (40,138) | | 1,394 | | (1,477) | | (21) | | 303 | | 0 | | 0 | | 0 | | 0 | | (19) | | 8,814 | | of which debt securities | | 2,292 | | 802 | | (904) | | 3,301 | | (3,261) | | 0 | | 0 | | 25 | | (150) | | 0 | | (3) | | 0 | | 0 | | (26) | | 2,076 | | of which foreign governments | | 270 | | 21 | | (12) | | 45 | | (67) | | 0 | | 0 | | 0 | | 4 | | 0 | | 0 | | 0 | | 0 | | (29) | | 232 | | of which corporates | | 1,412 | | 491 | | (593) | | 2,582 | | (2,583) | | 0 | | 0 | | 31 | | (72) | | 0 | | (4) | | 0 | | 0 | | (4) | | 1,260 | | of which RMBS | | 320 | | 211 | | (225) | | 370 | | (333) | | 0 | | 0 | | (3) | | (74) | | 0 | | 0 | | 0 | | 0 | | 3 | | 269 | | of which equity securities | | 163 | | 132 | | (95) | | 51 | | (185) | | 0 | | 0 | | 8 | | 55 | | 0 | | 3 | | 0 | | 0 | | 0 | | 132 | | of which derivatives | | 3,289 | | 510 | | (525) | | 0 | | 0 | | 1,394 | | (1,434) | | (56) | | 144 | | 0 | | 0 | | 0 | | 0 | | (24) | | 3,298 | | of which interest rate products | | 801 | | 18 | | (66) | | 0 | | 0 | | 100 | | (116) | | 17 | | (237) | | 0 | | 0 | | 0 | | 0 | | (10) | | 507 | | of which foreign exchange derivatives | | 188 | | 3 | | (2) | | 0 | | 0 | | 14 | | (24) | | (2) | | 79 | | 0 | | 0 | | 0 | | 0 | | 2 | | 258 | | of which equity/index-related products | | 833 | | 329 | | (317) | | 0 | | 0 | | 447 | | (436) | | (77) | | 300 | | 0 | | 0 | | 0 | | 0 | | (25) | | 1,054 | | of which credit derivatives | | 634 | | 160 | | (141) | | 0 | | 0 | | 505 | | (438) | | 5 | | (59) | | 0 | | 0 | | 0 | | 0 | | 7 | | 673 | | of which other derivatives | | 833 | | 0 | | 1 | | 0 | | 0 | | 328 | | (420) | | 1 | | 61 | | 0 | | 0 | | 0 | | 0 | | 2 | | 806 | | of which other trading assets | | 3,010 | | 119 | | (78) | | 36,705 | | (36,692) | | 0 | | (43) | | 2 | | 254 | | 0 | | 0 | | 0 | | 0 | | 31 | | 3,308 | | Investment securities | | 42 | | 8 | | (121) | | 281 | | (28) | | 0 | | (205) | | 0 | | 185 | | 0 | | 0 | | 0 | | 0 | | 4 | | 166 | | Other investments | | 1,601 | | 79 | | (102) | | 229 | | (406) | | 0 | | 0 | | 0 | | (93) | | 0 | | 5 | | 0 | | 0 | | (4) | | 1,309 | | of which life finance instruments | | 1,301 | | 0 | | 0 | | 151 | | (299) | | 0 | | 0 | | 0 | | (96) | | 0 | | 0 | | 0 | | 0 | | 10 | | 1,067 | | Loans | | 4,530 | | 934 | | (393) | | 163 | | (491) | | 1,563 | | (1,866) | | 7 | | (134) | | 0 | | (13) | | 0 | | 0 | | 24 | | 4,324 | | of which real estate | | 171 | | 196 | | (81) | | 0 | | 0 | | 307 | | (64) | | 2 | | (8) | | 0 | | (8) | | 0 | | 0 | | 0 | | 515 | | of which commercial and industrial loans | | 2,207 | | 348 | | (29) | | 1 | | (226) | | 783 | | (1,057) | | 0 | | (83) | | 0 | | (5) | | 0 | | 0 | | 10 | | 1,949 | | of which financial institutions | | 1,480 | | 335 | | (53) | | 150 | | (133) | | 332 | | (746) | | 10 | | 8 | | 0 | | 0 | | 0 | | 0 | | 8 | | 1,391 | | Other intangible assets (mortgage servicing rights) | | 158 | | 0 | | 0 | | 1 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 1 | | 0 | | 0 | | 3 | | 163 | | Other assets | | 1,511 | | 288 | | (191) | | 1,610 | | (1,357) | | 300 | | (540) | | 22 | | (32) | | 0 | | (1) | | 0 | | 0 | | (67) | | 1,543 | | of which loans held-for-sale | | 1,350 | | 243 | | (166) | | 1,447 | | (1,310) | | 300 | | (539) | | 21 | | (44) | | 0 | | 0 | | 0 | | 0 | | (67) | | 1,235 | | Total assets at fair value | | 16,642 | | 2,872 | | (2,424) | | 42,443 | | (42,523) | | 3,257 | | (4,088) | | 8 | | 229 | | 0 | | (8) | | 0 | | 0 | | (59) | | 16,349 | | Liabilities (CHF million) | Customer deposits | | 455 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 32 | | 0 | | 0 | | 0 | | (21) | | (13) | | 453 | | Obligation to return securities received as collateral | | 46 | | 0 | | (15) | | 102 | | (103) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 30 | | Trading liabilities | | 3,226 | | 768 | | (641) | | 127 | | (107) | | 2,573 | | (1,527) | | (7) | | (839) | | 0 | | (3) | | 0 | | 0 | | 19 | | 3,589 | | of which debt securities | | 2 | | 30 | | (24) | | 39 | | (23) | | 0 | | 0 | | 0 | | 1 | | 0 | | 0 | | 0 | | 0 | | 0 | | 25 | | of which equity securities | | 55 | | 19 | | (5) | | 87 | | (80) | | 0 | | 0 | | (3) | | (33) | | 0 | | (3) | | 0 | | 0 | | 0 | | 37 | | of which derivatives | | 3,169 | | 719 | | (612) | | 1 | | (4) | | 2,573 | | (1,527) | | (4) | | (807) | | 0 | | 0 | | 0 | | 0 | | 19 | | 3,527 | | of which interest rate derivatives | | 317 | | 25 | | (11) | | 0 | | 0 | | 156 | | (145) | | 16 | | (171) | | 0 | | 0 | | 0 | | 0 | | 2 | | 189 | | of which foreign exchange derivatives | | 100 | | 19 | | (1) | | 0 | | 0 | | 55 | | (29) | | 0 | | 15 | | 0 | | 0 | | 0 | | 0 | | 1 | | 160 | | of which equity/index-related derivatives | | 1,301 | | 429 | | (364) | | 0 | | 0 | | 1,306 | | (548) | | (36) | | (592) | | 0 | | 0 | | 0 | | 0 | | 4 | | 1,500 | | of which credit derivatives | | 898 | | 247 | | (235) | | 0 | | 0 | | 806 | | (572) | | 16 | | (30) | | 0 | | 0 | | 0 | | 0 | | 10 | | 1,140 | | Short-term borrowings | | 845 | | 335 | | (242) | | 0 | | 0 | | 1,090 | | (1,133) | | 3 | | (117) | | 0 | | (4) | | 0 | | 0 | | 7 | | 784 | | Long-term debt | | 12,501 | | 2,988 | | (3,108) | | 0 | | 0 | | 5,628 | | (3,656) | | (25) | | (1,368) | | 0 | | 0 | | (2) | | (417) | | 124 | | 12,665 | | of which structured notes over one year and up to two years | | 149 | | 452 | | (296) | | 0 | | 0 | | 745 | | (501) | | (10) | | (14) | | 0 | | 0 | | 0 | | 0 | | 3 | | 528 | | of which structured notes over two years | | 12,259 | | 2,368 | | (2,800) | | 0 | | 0 | | 4,761 | | (3,115) | | (17) | | (1,355) | | 0 | | 0 | | (2) | | (417) | | 118 | | 11,800 | | Other liabilities | | 1,478 | | 117 | | (29) | | 45 | | (128) | | 20 | | (420) | | (7) | | 97 | | 0 | | 161 | | 0 | | 0 | | 7 | | 1,341 | | Total liabilities at fair value | | 18,551 | | 4,208 | | (4,035) | | 274 | | (338) | | 9,311 | | (6,736) | | (36) | | (2,195) | | 0 | | 154 | | (2) | | (438) | | 144 | | 18,862 | | Net assets/(liabilities) at fair value | | (1,909) | | (1,336) | | 1,611 | | 42,169 | | (42,185) | | (6,054) | | 2,648 | | 44 | | 2,424 | | 0 | | (162) | | 2 | | 438 | | (203) | | (2,513) | | Assets and liabilities measured at fair value on a recurring basis for level 3 (continued) | | | | | | | | | | | | | | | | |
Trading revenues | |
Other revenues | | Accumulated other
comprehensive income | | | | | |
2017 | |
Balance at
beginning
of period | |
Transfers
in | |
Transfers
out | |
Purchases |
|
Sales |
|
Issuances |
|
Settlements | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | | Foreign
currency
translation
impact | |
Balance
at end
of period | | Assets (CHF million) | Interest-bearing deposits with banks | | 1 | | 40 | | 0 | | 0 | | (41) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 174 | | 0 | | 0 | | 0 | | 0 | | 26 | | (193) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | (7) | | 0 | | Securities received as collateral | | 70 | | 3 | | (1) | | 65 | | (86) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | (5) | | 46 | | Trading assets | | 12,765 | | 1,159 | | (2,046) | | 15,810 | | (18,032) | | 1,317 | | (2,068) | | 121 | | 252 | | 6 | | 1 | | 0 | | 0 | | (531) | | 8,754 | | of which debt securities | | 3,977 | | 608 | | (1,074) | | 2,747 | | (3,705) | | 0 | | 0 | | (4) | | (80) | | 6 | | 1 | | 0 | | 0 | | (184) | | 2,292 | | of which corporates | | 1,674 | | 276 | | (654) | | 2,203 | | (2,005) | | 0 | | 0 | | (4) | | 14 | | 6 | | 0 | | 0 | | 0 | | (98) | | 1,412 | | of which RMBS | | 605 | | 280 | | (229) | | 85 | | (305) | | 0 | | 0 | | 3 | | (95) | | 0 | | 0 | | 0 | | 0 | | (24) | | 320 | | of which CMBS | | 65 | | 6 | | (17) | | 2 | | (13) | | 0 | | 0 | | (3) | | (21) | | 0 | | 0 | | 0 | | 0 | | (3) | | 16 | | of which CDO | | 1,165 | | 39 | | (157) | | 174 | | (1,047) | | 0 | | 0 | | 0 | | (16) | | 0 | | 0 | | 0 | | 0 | | (32) | | 126 | | of which equity securities | | 240 | | 49 | | (35) | | 146 | | (260) | | 0 | | 0 | | 0 | | 33 | | 0 | | 0 | | 0 | | 0 | | (10) | | 163 | | of which derivatives | | 4,305 | | 416 | | (839) | | 0 | | 0 | | 1,317 | | (1,817) | | 123 | | (63) | | 0 | | 0 | | 0 | | 0 | | (153) | | 3,289 | | of which interest rate products | | 748 | | 56 | | (53) | | 0 | | 0 | | 118 | | (183) | | 6 | | 104 | | 0 | | 0 | | 0 | | 0 | | 5 | | 801 | | of which equity/index-related products | | 914 | | 142 | | (98) | | 0 | | 0 | | 443 | | (597) | | 14 | | 58 | | 0 | | 0 | | 0 | | 0 | | (43) | | 833 | | of which credit derivatives | | 688 | | 216 | | (252) | | 0 | | 0 | | 381 | | (297) | | 38 | | (110) | | 0 | | 0 | | 0 | | 0 | | (30) | | 634 | | of which other trading assets | | 4,243 | | 86 | | (98) | | 12,917 | | (14,067) | | 0 | | (251) | | 2 | | 362 | | 0 | | 0 | | 0 | | 0 | | (184) | | 3,010 | | Investment securities | | 72 | | 0 | | (17) | | 100 | | (113) | | 0 | | (90) | | (1) | | 95 | | 0 | | 0 | | 0 | | 0 | | (4) | | 42 | | Other investments | | 1,906 | | 23 | | (22) | | 350 | | (589) | | 0 | | 0 | | 0 | | 9 | | 0 | | 9 | | 0 | | 0 | | (85) | | 1,601 | | of which equity | | 318 | | 23 | | (22) | | 165 | | (171) | | 0 | | 0 | | 0 | | (7) | | 0 | | 9 | | 0 | | 0 | | (15) | | 300 | | of which life finance instruments | | 1,588 | | 0 | | 0 | | 185 | | (418) | | 0 | | 0 | | 0 | | 16 | | 0 | | 0 | | 0 | | 0 | | (70) | | 1,301 | | Loans | | 6,585 | | 1,130 | | (947) | | 106 | | (580) | | 1,151 | | (2,743) | | 15 | | 85 | | 0 | | 0 | | 0 | | 0 | | (272) | | 4,530 | | of which commercial and industrial loans | | 3,816 | | 448 | | (482) | | 71 | | (395) | | 590 | | (1,705) | | (2) | | 21 | | 0 | | 0 | | 0 | | 0 | | (155) | | 2,207 | | of which financial institutions | | 1,829 | | 352 | | (126) | | 33 | | (176) | | 444 | | (821) | | 28 | | (6) | | 0 | | 0 | | 0 | | 0 | | (77) | | 1,480 | | Other intangible assets (mortgage servicing rights) | | 138 | | 0 | | 0 | | 23 | | (1) | | 0 | | 0 | | 0 | | 0 | | 0 | | 4 | | 0 | | 0 | | (6) | | 158 | | Other assets | | 1,679 | | 347 | | (132) | | 759 | | (1,056) | | 1,054 | | (885) | | (1) | | (172) | | 0 | | (4) | | 0 | | 0 | | (78) | | 1,511 | | of which loans held-for-sale | | 1,316 | | 286 | | (113) | | 667 | | (904) | | 1,053 | | (885) | | (2) | | 0 | | 0 | | (4) | | 0 | | 0 | | (64) | | 1,350 | | Total assets at fair value | | 23,390 | | 2,702 | | (3,165) | | 17,213 | | (20,498) | | 3,548 | | (5,979) | | 134 | | 269 | | 6 | | 10 | | 0 | | 0 | | (988) | | 16,642 | | Liabilities (CHF million) | Customer deposits | | 410 | | 0 | | 0 | | 0 | | 0 | | 35 | | (3) | | 0 | | (61) | | 0 | | 0 | | 0 | | 42 | | 32 | | 455 | | Obligation to return securities received as collateral | | 70 | | 3 | | (1) | | 65 | | (86) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | (5) | | 46 | | Trading liabilities | | 3,737 | | 566 | | (1,049) | | 113 | | (134) | | 1,193 | | (1,625) | | 140 | | 461 | | 0 | | (9) | | 0 | | 0 | | (167) | | 3,226 | | of which interest rate derivatives | | 538 | | 57 | | (36) | | 0 | | 0 | | 45 | | (258) | | 6 | | (14) | | 0 | | 0 | | 0 | | 0 | | (21) | | 317 | | of which foreign exchange derivatives | | 150 | | 11 | | (1) | | 0 | | 0 | | 9 | | (12) | | 0 | | (52) | | 0 | | 0 | | 0 | | 0 | | (5) | | 100 | | of which equity/index-related derivatives | | 1,181 | | 54 | | (188) | | 0 | | 0 | | 543 | | (692) | | 17 | | 441 | | 0 | | 0 | | 0 | | 0 | | (55) | | 1,301 | | of which credit derivatives | | 851 | | 377 | | (392) | | 0 | | 0 | | 350 | | (376) | | 61 | | 66 | | 0 | | 0 | | 0 | | 0 | | (39) | | 898 | | Short-term borrowings | | 516 | | 95 | | (172) | | 0 | | 0 | | 865 | | (472) | | (2) | | 19 | | 4 | | 10 | | 0 | | 6 | | (24) | | 845 | | Long-term debt | | 13,415 | | 1,172 | | (3,004) | | 0 | | 0 | | 4,540 | | (4,479) | | (12) | | 1,400 | | 0 | | 0 | | 88 | | 21 | | (640) | | 12,501 | | of which structured notes over two years | | 12,434 | | 995 | | (2,886) | | 0 | | 0 | | 3,913 | | (3,079) | | (14) | | 1,390 | | 0 | | 0 | | 87 | | 17 | | (598) | | 12,259 | | Other liabilities | | 1,684 | | 150 | | (102) | | 211 | | (304) | | 9 | | (403) | | (25) | | (6) | | 0 | | 330 | | 0 | | 0 | | (66) | | 1,478 | | of which failed sales | | 219 | | 80 | | (70) | | 189 | | (218) | | 0 | | 0 | | (7) | | 40 | | 0 | | 0 | | 0 | | 0 | | (10) | | 223 | | Total liabilities at fair value | | 19,832 | | 1,986 | | (4,328) | | 389 | | (524) | | 6,642 | | (6,982) | | 101 | | 1,813 | | 4 | | 331 | | 88 | | 69 | | (870) | | 18,551 | | Net assets/(liabilities) at fair value | | 3,558 | | 716 | | 1,163 | | 16,824 | | (19,974) | | (3,094) | | 1,003 | | 33 | | (1,544) | | 2 | | (321) | | (88) | | (69) | | (118) | | (1,909) | | Gains and losses on assets and liabilities measured at fair value on a recurring basis (level 3) | | 2018 | | 2017 | |
in | | Trading
revenues | | Other
revenues | | Total
revenues | | Trading
revenues | | Other
revenues | | Total
revenues | | Gains and losses on assets and liabilities (CHF million) | Net realized/unrealized gains/(losses) included in net revenues | | 2,468 | | (162) | | 2,306 | 1 | (1,511) | | (319) | | (1,830) | 1 | Whereof: | | | | | | | | | | | | | | Unrealized gains/(losses) relating to assets and liabilities still held as of the reporting date | | (34) | | (5) | | (39) | | (2,088) | | 22 | | (2,066) | | 1 Excludes net realized/unrealized gains/(losses) attributable to foreign currency translation impact. | Both observable and unobservable inputs may be used to determine the fair value of positions that have been classified within level 3. As a result, the unrealized gains and losses for assets and liabilities within level 3 presented in the table above may include changes in fair value that were attributable to both observable and unobservable inputs. The Group employs various economic hedging techniques in order to manage risks, including risks in level 3 positions. Such techniques may include the purchase or sale of financial instruments that are classified in levels 1 and/or 2. The realized and unrealized gains and losses for assets and liabilities in level 3 presented in the table above do not reflect the related realized or unrealized gains and losses arising on economic hedging instruments classified in levels 1 and/or 2. Transfers in and out of level 3 Transfers into level 3 assets during 2018 were CHF 2,872 million, primarily from trading assets and loans. The transfers were primarily in the financing and credit businesses due to limited observability of pricing data and reduced pricing information from external providers. Transfers out of level 3 assets during 2018 were CHF 2,424 million, primarily in trading assets and loans. The transfers out of level 3 assets were primarily in the financing and fixed income businesses due to improved observability of pricing data and increased availability of pricing information from external providers. Transfers into level 3 assets during 2017 were CHF 2,702 million, primarily from trading assets and loans. The transfers were primarily in the credit, financing and fixed income businesses due to limited observability of pricing data and reduced pricing information from external providers. Transfers out of level 3 assets during 2017 were CHF 3,165 million, primarily in trading assets and loans. The transfers out of level 3 assets were primarily in the Strategic Resolution Unit and financing businesses due to improved observability of pricing data and increased availability of pricing information from external providers. Uncertainty of fair value measurements at the reporting date from the use of significant unobservable inputs For level 3 assets with a significant unobservable input of buyback probability, correlation, contingent probability, EBITDA multiple, funding spread, mortality rate, price, volatility or volatility skew, in general, an increase in the significant unobservable input would increase the fair value. For level 3 assets with a significant unobservable input of default rate, capitalization rate, credit curve for corporates or sovereigns, credit spread, discount rate, gap risk, market implied life expectancy (for life settlement and premium finance instruments), prepayment rate and recovery rate, in general, an increase in the significant unobservable input would decrease the fair value. For level 3 liabilities, in general, an increase in the related significant unobservable inputs would have the inverse impact on fair value. An increase in the significant unobservable input credit spread, contingent probability, gap risk, market implied life expectancy (for life settlement and premium finance instruments) and mortality would increase the fair value. An increase in the significant unobservable input basis spread, buyback probability, correlation, discount rate, fund gap risk, funding spread, mortality rate, prepayment rate, price, recovery rate and volatility would decrease the fair value. Interrelationships between significant unobservable inputs Except as noted above, there are no material interrelationships between the significant unobservable inputs for the financial instruments. As the significant unobservable inputs move independently, generally an increase or decrease in one significant unobservable input will have no impact on the other significant unobservable inputs. Quantitative disclosures of valuation techniques The following tables provide the representative range of minimum and maximum values and the associated weighted averages of each significant unobservable input for level 3 assets and liabilities by the related valuation technique most significant to the related financial instrument. Quantitative information about level 3 assets at fair value
end of 2018 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Securities received as collateral | | 30 | | – | | – | | – | | – | | – | | Trading assets | | 8,814 | | | | | | | | | | | | of which debt securities | | 2,076 | | | | | | | | | | | | of which foreign governments | | 232 | | Discounted cash flow | | Credit spread in bp | | 140 | | 140 | | 140 | | of which corporates | | 1,260 | | | | | | | | | | | | of which | | 441 | | Market comparable | | Price, in % | | 0 | | 118 | | 94 | | of which | | 621 | | Option model | | Correlation, in % | | (60) | | 98 | | 68 | | | | | | | | Volatility, in % | | 0 | | 178 | | 30 | | of which RMBS | | 269 | | Discounted cash flow | | Default rate, in % | | 0 | | 11 | | 3 | | | | | | | | Discount rate, in % | | 1 | | 26 | | 7 | | | | | | | | Loss severity, in % | | 0 | | 100 | | 63 | | | | | | | | Prepayment rate, in % | | 1 | | 22 | | 8 | | of which equity securities | | 132 | | | | | | | | | | | | of which | | 76 | | Market comparable | | EBITDA multiple | | 2 | | 9 | | 6 | | | | | | | | Price, in % | | 100 | | 100 | | 100 | | of which | | 49 | | Vendor price | | Price, in actuals | | 0 | | 355 | | 1 | | of which derivatives | | 3,298 | | | | | | | | | | | | of which interest rate products | | 507 | | Option model | | Correlation, in % | | 0 | | 100 | | 69 | | | | | | | | Prepayment rate, in % | | 1 | | 26 | | 9 | | | | | | | | Volatility skew, in % | | (4) | | 0 | | (2) | | of which foreign exchange products | | 258 | | | | | | | | | | | | of which | | 28 | | Discounted cash flow | | Contingent probability, in % | | 95 | | 95 | | 95 | | of which | | 218 | | Option model | | Correlation, in % | | (23) | | 70 | | 24 | | | | | | | | Prepayment rate, in % | | 21 | | 26 | | 23 | | | | | | | | Volatility, in % | | 80 | | 90 | | 85 | | of which equity/index-related products | | 1,054 | | Option model | | Buyback probability, in % | | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (40) | | 98 | | 80 | | | | | | | | Gap risk, in % | 2 | 0 | | 4 | | 1 | | | | | | | | Volatility, in % | | 2 | | 178 | | 34 | | of which credit derivatives | | 673 | | Discounted cash flow | | Correlation, in % | | 97 | | 97 | | 97 | | | | | | | | Credit spread, in bp | | 3 | | 2,147 | | 269 | | | | | | | | Default rate, in % | | 1 | | 20 | | 4 | | | | | | | | Discount rate, in % | | 3 | | 28 | | 15 | | | | | | | | Loss severity, in % | | 16 | | 85 | | 56 | | | | | | | | Prepayment rate, in % | | 0 | | 12 | | 6 | | | | | | | | Recovery rate, in % | | 0 | | 68 | | 8 | | of which other derivatives | | 806 | | Discounted cash flow | | Market implied life expectancy, in years | | 2 | | 16 | | 5 | | | | | | | | Mortality rate, in % | | 87 | | 106 | | 101 | | of which other trading assets | | 3,308 | | | | | | | | | | | | of which | | 870 | | Discounted cash flow | | Market implied life expectancy, in years | | 3 | | 17 | | 7 | | of which | | 2,119 | | Market comparable | | Price, in % | | 0 | | 110 | | 30 | | of which | | 249 | | Option model | | Mortality rate, in % | | 0 | | 70 | | 6 | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | Quantitative information about level 3 assets at fair value (continued)
end of 2018 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Investment securities | | 166 | | – | | – | | – | | – | | – | | Other investments | | 1,309 | | | | | | | | | | | | of which life finance instruments | | 1,067 | | Discounted cash flow | | Market implied life expectancy, in years | | 2 | | 17 | | 6 | | Loans | | 4,324 | | | | | | | | | | | | of which real estate | | 515 | | Discounted cash flow | | Credit spread, in bp | | 200 | | 1,522 | | 612 | | | | | | | | Recovery rate, in % | | 25 | | 40 | | 39 | | of which commercial and industrial loans | | 1,949 | | | | | | | | | | | | of which | | 1,531 | | Discounted cash flow | | Credit spread, in bp | | 159 | | 1,184 | | 582 | | of which | | 306 | | Market comparable | | Price, in % | | 0 | | 99 | | 65 | | of which financial institutions | | 1,391 | | | | | | | | | | | | of which | | 1,157 | | Discounted cash flow | | Credit spread, in bp | | 88 | | 1,071 | | 596 | | of which | | 73 | | Market comparable | | Price, in % | | 1 | | 100 | | 74 | | Other intangible assets (mortgage servicing rights) | | 163 | | – | | – | | – | | – | | – | | Other assets | | 1,543 | | | | | | | | | | | | of which loans held-for-sale | | 1,235 | | | | | | | | | | | | of which | | 422 | | Discounted cash flow | | Credit spread, in bp | | 105 | | 2,730 | | 394 | | | | | | | | Recovery rate, in % | | 25 | | 87 | | 56 | | of which | | 739 | | Market comparable | | Price, in % | | 0 | | 130 | | 82 | | Total level 3 assets at fair value | | 16,349 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | Quantitative information about level 3 assets at fair value (continued)
end of 2017 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Securities received as collateral | | 46 | | – | | – | | – | | – | | – | | Trading assets | | 8,754 | | | | | | | | | | | | of which debt securities | | 2,292 | | | | | | | | | | | | of which corporates | | 1,412 | | | | | | | | | | | | of which | | 387 | | Option model | | Correlation, in % | | (60) | | 98 | | 55 | | of which | | 545 | | Market comparable | | Price, in % | | 0 | | 139 | | 84 | | of which | | 444 | | Discounted cash flow | | Credit spread, in bp | | 37 | | 952 | | 230 | | of which RMBS | | 320 | | Discounted cash flow | | Discount rate, in % | | 1 | | 24 | | 11 | | | | | | | | Prepayment rate, in % | | 1 | | 36 | | 10 | | | | | | | | Default rate, in % | | 0 | | 12 | | 4 | | | | | | | | Loss severity, in % | | 0 | | 100 | | 57 | | of which CMBS | | 16 | | Discounted cash flow | | Capitalization rate, in % | | 14 | | 14 | | 14 | | | | | | | | Discount rate, in % | | 8 | | 16 | | 14 | | | | | | | | Prepayment rate, in % | | 0 | | 5 | | 4 | | of which CDO | | 126 | | Discounted cash flow | | Discount rate, in % | | 5 | | 13 | | 8 | | | | | | | | Prepayment rate, in % | | 5 | | 20 | | 13 | | | | | | | | Credit spread, in bp | | 464 | | 669 | | 553 | | | | | | | | Default rate, in % | | 2 | | 5 | | 3 | | | | | | | | Loss severity, in % | | 0 | | 80 | | 34 | | of which equity securities | | 163 | | | | | | | | | | | | of which | | 67 | | Vendor price | | Price, in actuals | | 0 | | 2,080 | | 10 | | of which | | 81 | | Market comparable | | EBITDA multiple | | 2 | | 9 | | 7 | | | | | | | | Price, in % | | 18 | | 100 | | 67 | | of which derivatives | | 3,289 | | | | | | | | | | | | of which interest rate products | | 801 | | Option model | | Correlation, in % | | 20 | | 100 | | 72 | | | | | | | | Prepayment rate, in % | | 6 | | 34 | | 17 | | | | | | | | Volatility skew, in % | | (4) | | 1 | | (1) | | of which equity/index-related products | | 833 | | Option model | | Correlation, in % | | (60) | | 98 | | 65 | | | | | | | | Volatility, in % | | 0 | | 105 | | 64 | | | | | | | | Buyback probability, in % | | 50 | | 100 | | 90 | | | | | | | | Gap risk, in % | 2 | 0 | | 2 | | 1 | | of which credit derivatives | | 634 | | Discounted cash flow | | Credit spread, in bp | | 1 | | 956 | | 217 | | | | | | | | Recovery rate, in % | | 0 | | 45 | | 20 | | | | | | | | Discount rate, in % | | 3 | | 50 | | 16 | | | | | | | | Default rate, in % | | 1 | | 20 | | 5 | | | | | | | | Loss severity, in % | | 1 | | 100 | | 64 | | | | | | | | Correlation, in % | | 97 | | 97 | | 97 | | | | | | | | Prepayment rate, in % | | 0 | | 14 | | 6 | | of which other trading assets | | 3,010 | | | | | | | | | | | | of which | | 1,605 | | Market comparable | | Price, in % | | 0 | | 110 | | 23 | | of which | | 1,095 | | Discounted cash flow | | Market implied life expectancy, in years | | 3 | | 18 | | 8 | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | Quantitative information about level 3 assets at fair value (continued)
end of 2017 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Investment securities | | 42 | | – | | – | | – | | – | | – | | Other investments | | 1,601 | | | | | | | | | | | | of which private equity | | 29 | | – | | – | | – | | – | | – | | of which other equity investments | | 271 | | – | | – | | – | | – | | – | | of which life finance instruments | | 1,301 | | Discounted cash flow | | Market implied life expectancy, in years | | 2 | | 18 | | 6 | | Loans | | 4,530 | | | | | | | | | | | | of which commercial and industrial loans | | 2,207 | | | | | | | | | | | | of which | | 1,924 | | Discounted cash flow | | Credit spread, in bp | | 89 | | 1,116 | | 420 | | of which | | 250 | | Market comparable | | Price, in % | | 0 | | 99 | | 56 | | of which financial institutions | | 1,480 | | | | | | | | | | | | of which | | 1,426 | | Discounted cash flow | | Credit spread, in bp | | 43 | | 1,430 | | 371 | | Other intangible assets (mortgage servicing rights) | | 158 | | – | | – | | – | | – | | – | | Other assets | | 1,511 | | | | | | | | | | | | of which loans held-for-sale | | 1,350 | | | | | | | | | | | | of which | | 849 | | Discounted cash flow | | Credit spread, in bp | | 117 | | 973 | | 292 | | | | | | | | Recovery rate, in % | | 18 | | 87 | | 73 | | of which | | 280 | | Market comparable | | Price, in % | | 0 | | 102 | | 88 | | Total level 3 assets at fair value | | 16,642 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | Quantitative information about level 3 liabilities at fair value
end of 2018 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Customer deposits | | 453 | | – | | – | | – | | – | | – | | Obligation to return securities received as collateral | | 30 | | – | | – | | – | | – | | – | | Trading liabilities | | 3,589 | | | | | | | | | | | | of which debt securities | | 25 | | – | | – | | – | | – | | – | | of which equity securities | | 37 | | Vendor price | | Price, in actuals | | 0 | | 3 | | 0 | | of which derivatives | | 3,527 | | | | | | | | | | | | of which interest rate derivatives | | 189 | | Option model | | Basis spread, in bp | | (20) | | 147 | | 48 | | | | | | | | Correlation, in % | | 1 | | 100 | | 41 | | | | | | | | Prepayment rate, in % | | 1 | | 26 | | 7 | | of which foreign exchange derivatives | | 160 | | | | | | | | | | | | of which | | 62 | | Discounted cash flow | | Contingent probability, in % | | 95 | | 95 | | 95 | | | | | | | | Credit spread, in bp | | 146 | | 535 | | 379 | | of which | | 37 | | Market comparable | | Price, in % | | 100 | | 100 | | 100 | | of which | | 57 | | Option model | | Correlation, in % | | 35 | | 70 | | 53 | | | | | | | | Prepayment rate, in % | | 21 | | 26 | | 23 | | of which equity/index-related derivatives | | 1,500 | | Option model | | Buyback probability, in % | 2 | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (60) | | 98 | | 74 | | | | | | | | Volatility, in % | | 0 | | 178 | | 30 | | of which credit derivatives | | 1,140 | | | | | | | | | | | | of which | | 566 | | Discounted cash flow | | Correlation, in % | | 38 | | 82 | | 47 | | | | | | | | Credit spread, in bp | | 3 | | 2,937 | | 262 | | | | | | | | Default rate, in % | | 1 | | 20 | | 4 | | | | | | | | Discount rate, in % | | 3 | | 28 | | 14 | | | | | | | | Loss severity, in % | | 16 | | 95 | | 56 | | | | | | | | Prepayment rate, in % | | 0 | | 12 | | 6 | | | | | | | | Recovery rate, in % | | 0 | | 80 | | 14 | | of which | | 508 | | Market comparable | | Price, in % | | 75 | | 104 | | 89 | | of which | | 20 | | Option model | | Correlation, in % | | 50 | | 50 | | 50 | | | | | | | | Credit spread, in bp | | 35 | | 1,156 | | 320 | | Short-term borrowings | | 784 | | | | | | | | | | | | of which | | 61 | | Discounted cash flow | | Credit spread, in bp | | 1,018 | | 1,089 | | 1,067 | | | | | | | | Recovery rate, in % | | 40 | | 40 | | 40 | | of which | | 644 | | Option model | | Buyback probability, in % | | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (40) | | 98 | | 64 | | | | | | | | Fund gap risk, in % | 3 | 0 | | 4 | | 1 | | | | | | | | Volatility, in % | | 2 | | 178 | | 32 | | Long-term debt | | 12,665 | | | | | | | | | | | | of which structured notes over one year and up to two years | | 528 | | | | | | | | | | | | of which | | 3 | | Discounted cash flow | | Credit spread, in bp | | 112 | | 112 | | 112 | | of which | | 427 | | Option model | | Correlation, in % | | (40) | | 98 | | 71 | | | | | | | | Volatility, in % | | 2 | | 178 | | 31 | | of which structured notes over two years | | 11,800 | | | | | | | | | | | | of which | | 1,570 | | Discounted cash flow | | Credit spread, in bp | | (11) | | 1,089 | | 136 | | of which | | 43 | | Market comparable | | Price, in % | | 0 | | 46 | | 30 | | of which | | 9,533 | | Option model | | Buyback probability, in % | 2 | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (60) | | 98 | | 65 | | | | | | | | Gap risk, in % | 3 | 0 | | 4 | | 1 | | | | | | | | Mean reversion, in % | 4 | (55) | | (1) | | (7) | | | | | | | | Volatility, in % | | 0 | | 178 | | 27 | | Other liabilities | | 1,341 | | – | | – | | – | | – | | – | | Total level 3 liabilities at fair value | | 18,862 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Estimate of the probability of structured notes being put back to the Group at the option of the investor over the remaining life of the financial instruments. | 3 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | 4 Management's best estimate of the speed at which interest rates will revert to the long-term average. | Quantitative information about level 3 liabilities at fair value (continued)
end of 2017 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Customer deposits | | 455 | | – | | – | | – | | – | | – | | Obligation to return securities received as collateral | | 46 | | – | | – | | – | | – | | – | | Trading liabilities | | 3,226 | | | | | | | | | | | | of which interest rate derivatives | | 317 | | | | | | | | | | | | of which | | 205 | | Option model | | Basis spread, in bp | | (25) | | 52 | | 19 | | | | | | | | Correlation, in % | | 20 | | 100 | | 60 | | | | | | | | Prepayment rate, in % | | 6 | | 34 | | 9 | | of which | | 81 | | Market comparable | | Price, in % | | 1 | | 102 | | 44 | | of which foreign exchange derivatives | | 100 | | | | | | | | | | | | of which | | 64 | | Option model | | Correlation, in % | | (10) | | 70 | | 51 | | | | | | | | Prepayment rate, in % | | 27 | | 34 | | 30 | | of which | | 7 | | Discounted cash flow | | Contingent probability, in % | | 95 | | 95 | | 95 | | of which equity/index-related derivatives | | 1,301 | | | | | | | | | | | | of which | | 947 | | Option model | | Correlation, in % | | (60) | | 98 | | 55 | | | | | | | | Volatility, in % | | 0 | | 105 | | 25 | | | | | | | | Buyback probability, in % | 2 | 50 | | 100 | | 90 | | of which | | 62 | | Vendor price | | Price, in actuals | | 0 | | 53 | | 18 | | of which credit derivatives | | 898 | | Discounted cash flow | | Credit spread, in bp | | 2 | | 973 | | 172 | | | | | | | | Discount rate, in % | | 3 | | 50 | | 16 | | | | | | | | Default rate, in % | | 1 | | 20 | | 5 | | | | | | | | Recovery rate, in % | | 10 | | 60 | | 38 | | | | | | | | Loss severity, in % | | 25 | | 100 | | 67 | | | | | | | | Correlation, in % | | 38 | | 85 | | 54 | | | | | | | | Prepayment rate, in % | | 0 | | 20 | | 7 | | | | | | | | Term TRS/repo spread, in bp | | 176 | | 176 | | 176 | | Short-term borrowings | | 845 | | | | | | | | | | | | of which | | 288 | | Option model | | Correlation, in % | | (40) | | 98 | | 60 | | | | | | | | Volatility, in % | | 4 | | 105 | | 26 | | of which | | 527 | | Discounted cash flow | | Credit spread, in bp | | 2 | | 278 | | 175 | | | | | | | | Recovery rate, in % | | 25 | | 40 | | 29 | | of which | | 24 | | Market comparable | | Price, in % | | 11 | | 47 | | 47 | | Long-term debt | | 12,501 | | | | | | | | | | | | of which structured notes over two years | | 12,259 | | | | | | | | | | | | of which | | 9,739 | | Option model | | Correlation, in % | | (60) | | 99 | | 55 | | | | | | | | Volatility, in % | | 0 | | 105 | | 21 | | | | | | | | Buyback probability, in % | 2 | 50 | | 100 | | 90 | | | | | | | | Gap risk, in % | 3 | 0 | | 2 | | 1 | | | | | | | | Mean reversion, in % | 4 | (14) | | (1) | | (6) | | of which | | 1,571 | | Discounted cash flow | | Credit spread, in bp | | 2 | | 729 | | 105 | | Other liabilities | | 1,478 | | | | | | | | | | | | of which failed sales | | 223 | | | | | | | | | | | | of which | | 122 | | Market comparable | | Price, in % | | 0 | | 100 | | 51 | | of which | | 25 | | Discounted cash flow | | Credit spread, in bp | | 1,430 | | 1,430 | | 1,430 | | Total level 3 liabilities at fair value | | 18,551 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Estimate of the probability of structured notes being put back to the Group at the option of the investor over the remaining life of the financial instruments. | 3 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | 4 Management's best estimate of the speed at which interest rates will revert to the long-term average. | Qualitative discussion of the ranges of significant unobservable inputs The following sections provide further information about the ranges of significant unobservable inputs included in the tables above. The level of aggregation and diversity within the financial instruments disclosed in the tables above results in certain ranges of significant inputs being wide and unevenly distributed across asset and liability categories. Basis spread Basis spread is the primary significant unobservable input for non-callable constant maturity treasury-CMS products and is used to determine interest rate risk as a result of differing lending and borrowing rates. Buyback probability Buyback probability is the probability assigned to structured notes being unwound prior to their legal maturity. Capitalization rate Capitalization rate is the primary significant unobservable input for CMBS loans and is used to estimate the potential return on investment. This is done by dividing the yearly income by the total value of the property. Contingent probability Contingent probability is the primary significant unobservable input for contingent foreign exchange forward trades where the delivery or exercise and the premium payment are contingent on an event such as completion of an M&A deal or regulatory approval for a product. Correlation There are many different types of correlation inputs, including credit correlation, cross-asset correlation (such as equity-interest rate correlation) and same-asset correlation (such as interest rate-interest rate correlation). Correlation inputs are generally used to value hybrid and exotic instruments. Due to the complex and unique nature of these instruments, the ranges for correlation inputs can vary widely across portfolios. Credit spread and recovery rate For financial instruments where credit spread is the significant unobservable input, the wide range represents positions with varying levels of risk. The lower end of the credit spread range typically represents shorter-dated instruments and/or those with better perceived credit risk. The higher end of the range typically comprises longer-dated financial instruments or those referencing non-performing, distressed or impaired reference credits. Similarly, the spread between the reference credit and an index can vary significantly based on the risk of the instrument. The spread will be positive for instruments that have a higher risk of default than the index (which is based on a weighted average of its components) and negative for instruments that have a lower risk of default than the index. Similarly, recovery rates can vary significantly depending upon the specific assets and terms of each transaction. Transactions with higher seniority or more valuable collateral will have higher recovery rates, while those transactions which are more subordinated or with less valuable collateral will have lower recovery rates. Default rate and loss severity For financial instruments backed by residential real estate or other assets, diversity in the portfolio is reflected in a wide range for loss severity due to varying levels of default. The lower end of the range represents high performing or government guaranteed collateral with a low PD or guaranteed timely payment of principal and interest, while the higher end of the range relates to collateral with a greater risk of default. Discount rate The discount rate is the rate of interest used to calculate the present value of the expected cash flows of a financial instrument. There are multiple factors that will impact the discount rate for any given financial instrument including the coupon on the instrument, the term and the underlying risk of the expected cash flows. Two instruments of similar term and expected cash flows may have significantly different discount rates because the coupons on the instruments are different. EBITDA multiple EBITDA multiple is a primary significant unobservable input for some equity deals which are benchmarked using industry comparables. The EBITDA multiple may be preferred over other measures because it is normalized for differences between the accounting policies of similar companies. Funding spread Funding spread is the primary significant unobservable input for special purpose vehicle funding facilities. Synthetic funding curves which represent the assets pledged as collateral are used to value structured financing transactions. The curves provide an estimate of where secured funding can be sourced and are expressed as a basis point spread in relation to the referenced benchmark rate. Gap risk Gap risk is the primary significant unobservable input for fund-linked Constant Proportion Portfolio Insurance products and structures where the payoff may be sensitive to discontinuity in the hedging portfolio. Market implied life expectancy Market implied life expectancy is the primary significant unobservable input on such products as life settlement, premium finance and SPIA, and represents the estimated mortality rate for the underlying insured for each contract. This estimate may vary depending upon multiple factors including the age and specific health characteristics of the insured. Mean reversion Mean reversion is the primary significant unobservable input for callable constant maturity swap (CMS) spread exotics and represents the idea that prices and returns eventually move back towards the historical average. Mortality rate Mortality rate is the primary significant unobservable input for pension swaps. The expected present value of future cash flow of the trades depend on the mortality of individuals in the pension fund who are grouped into categories such as gender, age, pension amount and other factors. In some cases mortality rates include a “scaler” (also referred to as a loading or multiplier) that align mortality projections with historical experience and calibrate to exit level. Prepayment rate Prepayment rates may vary from collateral pool to collateral pool, and are driven by a variety of collateral-specific factors, including the type and location of the underlying borrower, the remaining tenor of the obligation and the level and type (e.g., fixed or floating) of interest rate being paid by the borrower. Price Bond equivalent price is a primary significant unobservable input for multiple products. Where market prices are not available for an instrument, benchmarking may be utilized to identify comparable issues (same industry and similar product mixes) while adjustments are considered for differences in deal terms and performance. Term TRS/repo spread For financial instruments where TRS/repo spread is the significant unobservable input, the range represents positions with varying levels of risk. The lower end of the spread range typically represents shorter-dated instruments and/or those with better perceived credit and funding risk. The higher end of the range typically comprises longer-dated financial instruments or those referencing collateral with lower liquidity or collateral correlated to the counterparty. Volatility and volatility skew Volatility and its skew are both impacted by the underlying risk, term and strike price of the derivative. In the case of interest rate derivatives, volatility may vary significantly between different underlying currencies and expiration dates on the options. Similarly, in the case of equity derivatives, the volatility attributed to a structure may vary depending upon the underlying reference name on the derivative. Investment funds measured at NAV per share Investments in funds held in trading assets and trading liabilities primarily include positions held in equity funds of funds as an economic hedge for structured notes and derivatives issued to clients that reference the same underlying risk and liquidity terms of the fund. A majority of these funds have limitations imposed on the amount of withdrawals from the fund during the redemption period due to illiquidity of the investments. In other instances, the withdrawal amounts may vary depending on the redemption notice period and are usually larger for the longer redemption notice periods. In addition, penalties may apply if redemption is within a certain time period from initial investment. Investments in funds held in other investments principally involves private equity securities and, to a lesser extent, publicly traded securities and fund of funds. Several of these investments have redemption restrictions subject to the discretion of the board of directors of the fund and/or redemption is permitted without restriction, but is limited to a certain percentage of total assets or only after a certain date. For those funds held in trading assets and trading liabilities and funds held in other investments that are nonredeemable, the underlying assets of such funds are expected to be liquidated over the life of the fund, which is generally up to ten years. The following table pertains to investments in certain entities that calculate NAV per share or its equivalent, primarily private equity and hedge funds. These investments do not have a readily determinable fair value and are measured at fair value using NAV. Fair value, unfunded commitments and term of redemption conditions of investment funds measured at NAV per share | | 2018 | | 2017 | |
end of | |
Non-
redeemable | |
Redeemable | |
Total
fair value | | Unfunded
commit-
ments | |
Non-
redeemable | |
Redeemable | |
Total
fair value | | Unfunded
commit-
ments | | Fair value of investment funds and unfunded commitments (CHF million) | Debt funds | | 12 | | 0 | | 12 | | 0 | | 0 | | 0 | | 0 | | 0 | | Equity funds | | 103 | | 1,011 | 1 | 1,114 | | 53 | | 61 | | 992 | 2 | 1,053 | | 0 | | Equity funds sold short | | (8) | | (2) | | (10) | | 0 | | 0 | | (9) | | (9) | | 0 | | Funds held in trading assets and trading liabilities | | 107 | | 1,009 | | 1,116 | | 53 | | 61 | | 983 | | 1,044 | | 0 | | Debt funds | | 1 | | 0 | | 1 | | 0 | | 1 | | 0 | | 1 | | 0 | | Equity funds | | 130 | | 0 | | 130 | | 43 | | 141 | | 0 | | 141 | | 64 | | Real estate funds | | 214 | | 0 | | 214 | | 34 | | 178 | | 0 | | 178 | | 44 | | Other private equity funds | | 24 | | 5 | | 29 | | 29 | | 31 | | 0 | | 31 | | 15 | | Private equity funds | | 369 | | 5 | | 374 | | 106 | | 351 | | 0 | | 351 | | 123 | | Debt funds | | 68 | | 34 | | 102 | | 0 | | 164 | | 75 | | 239 | | 0 | | Equity funds | | 14 | | 14 | | 28 | | 0 | | 2 | | 53 | | 55 | | 0 | | Other hedge funds | | 2 | | 24 | | 26 | | 0 | | 2 | | 95 | | 97 | | 9 | | Hedge funds | | 84 | | 72 | 3 | 156 | | 0 | | 168 | | 223 | 4 | 391 | | 9 | | Equity method investment funds | | 52 | | 522 | | 574 | | 21 | | 71 | | 1,051 | | 1,122 | | 5 | | Funds held in other investments | | 505 | | 599 | | 1,104 | | 127 | | 590 | | 1,274 | | 1,864 | | 137 | | Total fair value of investment funds and unfunded commitments | | 612 | 5 | 1,608 | | 2,220 | | 180 | 7 | 651 | 5 | 2,257 | 6 | 2,908 | | 137 | 7 | 1 46% of the redeemable fair value amount of equity funds is redeemable on demand with a notice period primarily of less than 30 days, 40% is redeemable on a monthly basis with a notice period of primarily more than 30 days, 13% is redeemable on a quarterly basis with a notice period primarily of more than 45 days and 1% is redeemable on an annual basis with a notice period of less than 30 days. | 2 54% of the redeemable fair value amount of equity funds is redeemable on demand with a notice period primarily of less than 30 days, 35% is redeemable on a monthly basis with a notice period primarily of less than 30 days, 9% is redeemable on a quarterly basis with a notice period primarily of more than 45 days and 2% is redeemable on an annual basis with a notice period of more than 60 days. | 3 65% of the redeemable fair value amount of hedge funds is redeemable on a quarterly basis with a notice period primarily of more than 60 days and 35% is redeemable on demand with a notice period primarily of less than 30 days. | 4 51% of the redeemable fair value amount of hedge funds is redeemable on a quarterly basis with a notice period primarily of more than 45 days, 43% is redeemable on a monthly basis with a notice period primarily of less than 30 days and 6% is redeemable on demand with a notice period primarily of less than 30 days. | 5 Includes CHF 102 million and CHF 229 million attributable to noncontrolling interests as of the end of 2018 and 2017, respectively. | 6 Includes CHF 167 million attributable to noncontrolling interests as of the end of 2017. | 7 Includes CHF 23 million and CHF 53 million attributable to noncontrolling interests as of the end of 2018 and 2017, respectively. | Assets measured at fair value on a nonrecurring basis Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances, for example, when there is evidence of impairment. Nonrecurring measurements are completed as of the end of the period unless otherwise stated. Assets measured at fair value on a nonrecurring basis end of | | 2018 | | 2017 | | CHF billion | Assets held-for-sale recorded at fair value on a nonrecurring basis | | 0.0 | | 0.1 | | of which level 2 | | 0.0 | | 0.1 | | The Group typically uses nonfinancial assets measured at fair value on a recurring or nonrecurring basis in a manner that reflects their highest and best use. The Group has availed itself of the simplification in accounting offered under the fair value option. This has been accomplished generally by electing the fair value option, both at initial adoption and for subsequent transactions, on items impacted by the hedge accounting requirements of US GAAP. For instruments for which hedge accounting could not be achieved but for which the Group is economically hedged, the Group has generally elected the fair value option. Where the Group manages an activity on a fair value basis but previously has been unable to achieve fair value accounting, the Group has generally utilized the fair value option to align its financial accounting to its risk management reporting. The Group elected fair value for certain of its financial statement captions as follows: Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions The Group has elected to account for structured resale agreements and most matched book resale agreements at fair value. These activities are managed on a fair value basis; thus, fair value accounting is deemed more appropriate for reporting purposes. The Group did not elect the fair value option for firm financing resale agreements as these agreements are generally overnight agreements which approximate fair value, but which are not managed on a fair value basis. Other investments The Group has elected to account for certain equity method investments at fair value. These activities are managed on a fair value basis; thus, fair value accounting is deemed more appropriate for reporting purposes. Certain similar instruments, such as those relating to equity method investments in strategic relationships, for example, the Group’s ownership interest in certain clearance organizations, which were eligible for the fair value option, were not elected due to the strategic relationship. Loans The Group has elected to account for substantially all commercial loans and loan commitments from the investment banking businesses and certain emerging market loans from the investment banking businesses at fair value. These activities are managed on a fair value basis and fair value accounting was deemed more appropriate for reporting purposes. Additionally, recognition on a fair value basis eliminates the mismatch that existed due to the economic hedging the Group employs to manage these loans. Certain similar loans, such as project finance, lease finance, cash collateralized and some bridge loans, which were eligible for the fair value option, were not elected due to the lack of currently available infrastructure to fair value such loans and/or the inability to economically hedge such loans. Additionally, the Group elected not to account for loans granted by its private, corporate and institutional banking businesses at fair value, such as domestic consumer lending, mortgages and corporate loans, as these loans are not managed on a fair value basis. Other assets The Group elected the fair value option for loans held-for-sale, due to the short period over which such loans are held and the intention to sell such loans in the near term. Other assets also include assets of VIEs and mortgage securitizations which do not meet the criteria for sale treatment under US GAAP. The Group did elect the fair value option for these types of transactions. Due to banks and customer deposits The Group elected the fair value option for certain time deposits associated with its emerging markets activities. The Group’s customer deposits include fund-linked deposits. The Group elected the fair value option for these fund-linked deposits. Fund-linked products are managed on a fair value basis and fair value accounting was deemed more appropriate for reporting purposes. Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions The Group has elected to account for structured repurchase agreements and most matched book repurchase agreements at fair value. These activities are managed on a fair value basis and fair value accounting was deemed more appropriate for reporting purposes. The Group did not elect the fair value option for firm financing repurchase agreements as these agreements are generally overnight agreements which approximate fair value, but which are not managed on a fair value basis. Short-term borrowings The Group’s short-term borrowings include hybrid debt instruments with embedded derivative features. Some of these embedded derivative features create bifurcatable debt instruments. The Group elected the fair value option for some of these instruments as of January 1, 2006, in accordance with the provisions of US GAAP. New bifurcatable debt instruments which were entered into in 2006 are carried at fair value. Some hybrid debt instruments do not result in bifurcatable debt instruments. US GAAP permits the Group to elect fair value accounting for non-bifurcatable hybrid debt instruments. With the exception of certain bifurcatable hybrid debt instruments which the Group did not elect to account for at fair value, the Group has elected to account for all hybrid debt instruments held as of January 1, 2007, and hybrid debt instruments originated after January 1, 2007, at fair value. These activities are managed on a fair value basis and fair value accounting was deemed appropriate for reporting purposes. There are two main populations of similar instruments for which fair value accounting was not elected. The first relates to the lending business transacted by the Group’s private, corporate and institutional banking businesses, which includes structured deposits and similar investment products. These are managed on a bifurcated or accrual basis and fair value accounting was not considered appropriate. The second is where the instruments were or will be maturing in the near term and their fair value will be realized at that time. Long-term debt The Group’s long-term debt includes hybrid debt instruments with embedded derivative features as described above in short-term borrowings. The Group’s long-term debt also includes debt issuances managed by the Treasury department that do not contain derivative features (vanilla debt). The Group actively manages the interest rate risk on these instruments with derivatives. In particular, fixed-rate debt is hedged with receive-fixed, pay-floating interest rate swaps. The Group elected to fair value fixed-rate debt upon implementation of the fair value option on January 1, 2007, with changes in fair value recognized as a component of trading revenues. The Group did not elect to apply the fair value option to fixed-rate debt issued by the Group since January 1, 2008, but instead applies hedge accounting. Other liabilities Other liabilities include liabilities of VIEs and mortgage securitizations that do not meet the criteria for sale treatment under US GAAP. The Group elected the fair value option for these types of transactions. Difference between the aggregate fair value and unpaid principal balances of fair value option-elected financial instruments | | 2018 | | 2017 | |
end of | | Aggregate
fair
value | | Aggregate
unpaid
principal | |
Difference | | Aggregate
fair
value | | Aggregate
unpaid
principal | |
Difference | | Financial instruments (CHF million) | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 81,818 | | 81,637 | | 181 | | 77,498 | | 76,643 | | 855 | | Loans | | 14,873 | | 15,441 | | (568) | | 15,307 | | 15,372 | | (65) | | Other assets 1 | | 6,706 | | 9,240 | | (2,534) | | 8,468 | | 10,910 | | (2,442) | | Due to banks and customer deposits | | (859) | | (778) | | (81) | | (907) | | (861) | | (46) | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | (14,828) | | (14,827) | | (1) | | (15,262) | | (15,180) | | (82) | | Short-term borrowings | | (8,068) | | (8,647) | | 579 | | (11,019) | | (11,104) | | 85 | | Long-term debt | | (63,935) | | (70,883) | | 6,948 | | (63,628) | | (63,759) | | 131 | | Other liabilities | | (2,068) | | (3,125) | | 1,057 | | (661) | | (1,716) | | 1,055 | | | | | | | | | | | | | | | | Non-performing and non-interest-earning loans 2 | | 640 | | 3,493 | | (2,853) | | 708 | | 3,375 | | (2,667) | | 1 Primarily loans held-for-sale. | 2 Included in loans or other assets. | Gains and losses on financial instruments | | 2018 | | 2017 | | 2016 | |
in | | Net
gains/
(losses) | | Net
gains/
(losses) | | Net
gains/
(losses) | | Financial instruments (CHF million) | Interest-bearing deposits with banks | | 2 | 1 | 13 | 1 | 4 | 1 | of which related to credit risk | | (10) | | 0 | | 1 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 2,451 | 1 | 2,206 | 1,4 | 1,440 | 1 | Other investments | | 241 | 3 | 216 | 2 | 212 | 2 | of which related to credit risk | | (1) | | (4) | | (3) | | Loans | | 717 | 1 | 1,542 | 1 | 1,643 | 1 | of which related to credit risk | | (296) | | 7 | | (16) | | Other assets | | 770 | 1 | 480 | 1 | (518) | 2 | of which related to credit risk | | 61 | | 96 | | (199) | | Due to banks and customer deposits | | (39) | 2 | 1 | 2 | (12) | 1 | of which related to credit risk | | (37) | | 5 | | (22) | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | (890) | 1 | (418) | 1,4 | (112) | 1 | Short-term borrowings | | 2,807 | 2 | (512) | 2 | 323 | 2 | of which related to credit risk | | (5) | | (23) | | (4) | | Long-term debt | | 4,206 | 2 | (6,857) | 2 | (1,235) | 2 | of which related to credit risk | | 7 | | (32) | | 22 | | Other liabilities | | 73 | 3 | 183 | 3 | 456 | 2 | of which related to credit risk | | 4 | | 83 | | 306 | | 1 Primarily recognized in net interest income. | 2 Primarily recognized in trading revenues. | 3 Primarily recognized in other revenues. | 4 Prior period has been corrected. | The impact of credit risk on assets presented in the table above has been calculated as the component of the total change in fair value, excluding the impact of changes in base or risk-free interest rates. The impact of changes in own credit risk on liabilities presented in the table above has been calculated as the difference between the fair values of those instruments as of the reporting date and the theoretical fair values of those instruments calculated by using the yield curve prevailing at the end of the reporting period, adjusted up or down for changes in the Group’s own credit spreads from the transition date to the reporting date. Interest income and expense, which are calculated based on contractual rates specified in the transactions, are recorded in the consolidated statements of operations depending on the nature of the instrument and its related market convention. When interest is included as a component of the change in the instrument’s fair value, it is included in trading revenues. Otherwise, it is included in interest and dividend income or interest expense. Interest and dividend income is recognized separately from trading revenues. Gains and losses attributable to changes in instrument-specific credit risk on fair value option elected liabilities The following table provides additional information regarding the gains and losses attributable to changes in instrument-specific credit risk on fair value option elected liabilities, which have been recorded in AOCI. The table includes both the amount of change during the period and the cumulative amount that were attributable to the changes in instrument-specific credit risk. In addition, the table includes the gains and losses related to instrument-specific credit risk, which were previously recorded in AOCI but have been transferred to net income during the period. Gains/(losses) attributable to changes in instrument-specific credit risk | |
Gains/(losses) recorded into AOCI | 1 | Gains/(losses) recorded
in AOCI transferred
to net income | 1 | in | | 2018 | | Cumulative | | 2017 | | 2018 | | 2017 | | Financial instruments (CHF million) | Customer deposits | | 36 | | (21) | | (15) | | (6) | | 0 | | Short-term borrowings | | 6 | | (53) | | (63) | | 2 | | 0 | | Long-term debt | | 1,603 | | (924) | | (1,957) | | 53 | | 32 | | of which treasury debt over two years | | 759 | | 84 | | (702) | | 0 | | 0 | | of which structured notes over two years | | 774 | | (1,060) | | (1,246) | | 53 | | 27 | | Total | | 1,645 | | (998) | | (2,035) | | 49 | | 32 | | 1 Amounts are reflected gross of tax. | Financial instruments not carried at fair value The “Carrying value and fair value of financial instruments not carried at fair value” table provides the carrying value and fair value of financial instruments which are not carried at fair value in the consolidated balance sheet. The disclosure excludes all non-financial instruments such as lease transactions, real estate, premises and equipment, equity method investments and pension and benefit obligations. Carrying value and fair value of financial instruments not carried at fair value | | Carrying
value | |
Fair value | | end of | | | | Level 1 | | Level 2 | | Level 3 | | Total | | 2018 (CHF million) | Financial assets | | | | | | | | | | | | Central banks funds sold, securities purchased under resale agreements and securities borrowing transactions | | 35,277 | | 0 | | 35,243 | | 35 | | 35,278 | | Loans | | 269,147 | | 0 | | 269,825 | | 7,047 | | 276,872 | | Other financial assets 1 | | 117,353 | | 99,976 | | 16,750 | | 797 | | 117,523 | | Financial liabilities | | | | | | | | | | | | Due to banks and customer deposits | | 375,403 | | 196,674 | | 178,755 | | 0 | | 375,429 | | Central banks funds purchased, securities sold under repurchase agreements and securities lending transactions | | 9,795 | | 0 | | 9,795 | | 0 | | 9,795 | | Short-term borrowings | | 13,857 | | 0 | | 13,859 | | 0 | | 13,859 | | Long-term debt | | 90,373 | | 0 | | 89,651 | | 854 | | 90,505 | | Other financial liabilities 2 | | 16,357 | | 0 | | 16,101 | | 184 | | 16,285 | | 2017 (CHF million) | Financial assets | | | | | | | | | | | | Central banks funds sold, securities purchased under resale agreements and securities borrowing transactions | | 37,848 | | 0 | | 37,848 | | 0 | | 37,848 | | Loans | | 260,093 | | 0 | | 264,290 | | 3,212 | | 267,502 | | Other financial assets 1,3 | | 170,870 | | 109,645 | | 60,469 | | 1,109 | | 171,223 | | Financial liabilities | | | | | | | | | | | | Due to banks and customer deposits | | 372,867 | | 201,575 | | 171,281 | | 0 | | 372,856 | | Central banks funds purchased, securities sold under repurchase agreements and securities lending transactions | | 11,233 | | 0 | | 11,233 | | 0 | | 11,233 | | Short-term borrowings | | 14,871 | | 0 | | 14,870 | | 0 | | 14,870 | | Long-term debt | | 109,403 | | 0 | | 112,488 | | 235 | | 112,723 | | Other financial liabilities 2,3 | | 61,316 | | 0 | | 61,131 | | 172 | | 61,303 | | 1 Primarily includes cash and due from banks, interest-bearing deposits with banks, loans held-for-sale, cash collateral on derivative instruments, interest and fee receivables and non-marketable equity securities. | 2 Primarily includes cash collateral on derivative instruments and interest and fee payables. | 3 2017 balances included brokerage receivables and payables, which, effective January 1, 2018, were no longer included due to the adoption of ASU 2016-01. |
|
Financial instruments |
34 Financial instruments > Refer to “Note 35 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group for further information. Assets and liabilities measured at fair value on a recurring basis
end of 2018 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Assets
measured
at net
asset value
per share | 2 |
Total | | Assets (CHF million) | Cash and due from banks | | 0 | | 115 | | 0 | | – | | – | | 115 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 0 | | 81,818 | | 0 | | – | | – | | 81,818 | | Securities received as collateral | | 37,962 | | 3,704 | | 30 | | – | | – | | 41,696 | | Trading assets | | 76,178 | | 156,239 | | 8,814 | | (109,930) | | 1,126 | | 132,427 | | of which debt securities | | 23,726 | | 36,402 | | 2,076 | | – | | 12 | | 62,216 | | of which foreign government | | 23,547 | | 4,542 | | 232 | | – | | – | | 28,321 | | of which corporates | | 66 | | 8,065 | | 1,260 | | – | | 12 | | 9,403 | | of which RMBS | | 0 | | 19,652 | | 269 | | – | | – | | 19,921 | | of which equity securities | | 42,812 | | 2,459 | | 132 | | – | | 1,114 | | 46,517 | | of which derivatives | | 8,000 | | 117,034 | | 3,298 | | (109,930) | | – | | 18,402 | | of which interest rate products | | 3,557 | | 65,823 | | 507 | | – | | – | | – | | of which foreign exchange products | | 25 | | 27,526 | | 258 | | – | | – | | – | | of which equity/index-related products | | 4,415 | | 18,059 | | 1,054 | | – | | – | | – | | of which credit derivatives | | 0 | | 4,739 | | 673 | | – | | – | | – | | of which other derivatives | | 2 | | 633 | | 806 | | – | | – | | – | | of which other trading assets | | 1,640 | | 344 | | 3,308 | | – | | – | | 5,292 | | Investment securities | | 0 | | 2,743 | | 166 | | – | | – | | 2,909 | | Other investments | | 14 | | 7 | | 1,309 | | – | | 1,100 | | 2,430 | | of which life finance instruments | | 0 | | 0 | | 1,067 | | – | | – | | 1,067 | | Loans | | 0 | | 10,549 | | 4,324 | | – | | – | | 14,873 | | of which real estate | | 0 | | 146 | | 515 | | – | | – | | 661 | | of which commercial and industrial loans | | 0 | | 3,976 | | 1,949 | | – | | – | | 5,925 | | of which financial institutions | | 0 | | 4,164 | | 1,391 | | – | | – | | 5,555 | | Other intangible assets (mortgage servicing rights) | | 0 | | 0 | | 163 | | – | | – | | 163 | | Other assets | | 117 | | 5,807 | | 1,543 | | (204) | | – | | 7,263 | | of which loans held-for-sale | | 0 | | 4,238 | | 1,235 | | – | | – | | 5,473 | | Total assets at fair value | | 114,271 | | 260,982 | | 16,349 | | (110,134) | | 2,226 | | 283,694 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis (continued)
end of 2018 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Liabilities
measured
at net
asset value
per share | 2 |
Total | | Liabilities (CHF million) | Due to banks | | 0 | | 406 | | 0 | | – | | – | | 406 | | Customer deposits | | 0 | | 2,839 | | 453 | | – | | – | | 3,292 | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | 0 | | 14,828 | | 0 | | – | | – | | 14,828 | | Obligation to return securities received as collateral | | 37,962 | | 3,704 | | 30 | | – | | – | | 41,696 | | Trading liabilities | | 31,940 | | 123,737 | | 3,589 | | (117,105) | | 10 | | 42,171 | | of which debt securities | | 4,462 | | 3,511 | | 25 | | – | | – | | 7,998 | | of which foreign government | | 4,328 | | 255 | | 0 | | – | | – | | 4,583 | | of which equity securities | | 18,785 | | 118 | | 37 | | – | | 10 | | 18,950 | | of which derivatives | | 8,693 | | 120,108 | | 3,527 | | (117,105) | | – | | 15,223 | | of which interest rate products | | 3,699 | | 62,573 | | 189 | | – | | – | | – | | of which foreign exchange products | | 32 | | 31,983 | | 160 | | – | | – | | – | | of which equity/index-related products | | 4,961 | | 19,788 | | 1,500 | | – | | – | | – | | of which credit derivatives | | 0 | | 5,485 | | 1,140 | | – | | – | | – | | Short-term borrowings | | 0 | | 7,284 | | 784 | | – | | – | | 8,068 | | Long-term debt | | 0 | | 50,356 | | 12,671 | | – | | – | | 63,027 | | of which structured notes over one year and up to two years | | 0 | | 7,242 | | 528 | | – | | – | | 7,770 | | of which structured notes over two years | | 0 | | 28,215 | | 11,800 | | – | | – | | 40,015 | | Other liabilities | | 0 | | 7,877 | | 1,327 | | (221) | | – | | 8,983 | | Total liabilities at fair value | | 69,902 | | 211,031 | | 18,854 | | (117,326) | | 10 | | 182,471 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis (continued)
end of 2017 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Assets
measured
at net
asset value
per share | 2 |
Total | | Assets (CHF million) | Cash and due from banks | | 0 | | 212 | | 0 | | – | | – | | 212 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 0 | | 77,498 | | 0 | | – | | – | | 77,498 | | Securities received as collateral | | 36,697 | | 1,331 | | 46 | | – | | – | | 38,074 | | of which debt securities | | 576 | | 802 | | 0 | | – | | – | | 1,378 | | of which corporates | | 0 | | 726 | | 0 | | – | | – | | 726 | | of which equity securities | | 36,121 | | 529 | | 46 | | – | | – | | 36,696 | | Trading assets | | 87,452 | | 188,122 | | 8,754 | | (128,607) | | 1,053 | | 156,774 | | of which debt securities | | 29,827 | | 40,707 | | 2,292 | | – | | – | | 72,826 | | of which foreign governments | | 29,561 | | 4,256 | | 270 | | – | | – | | 34,087 | | of which corporates | | 179 | | 10,292 | | 1,412 | | – | | – | | 11,883 | | of which RMBS | | 0 | | 21,399 | | 320 | | – | | – | | 21,719 | | of which CMBS | | 0 | | 2,501 | | 16 | | – | | – | | 2,517 | | of which CDO | | 0 | | 2,255 | | 126 | | – | | – | | 2,381 | | of which equity securities | | 51,125 | | 3,481 | | 163 | | – | | 1,053 | | 55,822 | | of which derivatives | | 3,577 | | 141,641 | | 3,289 | | (128,607) | | – | | 19,900 | | of which interest rate products | | 1,219 | | 84,932 | | 801 | | – | | – | | – | | of which foreign exchange products | | 19 | | 30,302 | | 188 | | – | | – | | – | | of which equity/index-related products | | 2,339 | | 18,544 | | 833 | | – | | – | | – | | of which credit derivatives | | 0 | | 7,107 | | 634 | | – | | – | | – | | Other trading assets | | 2,923 | | 2,293 | | 3,010 | | – | | – | | 8,226 | | Investment securities | | 250 | | 1,897 | | 42 | | – | | – | | 2,189 | | of which debt securities | | 244 | | 1,778 | | 42 | | – | | – | | 2,064 | | of which foreign governments | | 98 | | 1,138 | | 0 | | – | | – | | 1,236 | | of which corporates | | 0 | | 238 | | 0 | | – | | – | | 238 | | of which RMBS | | 0 | | 167 | | 40 | | – | | – | | 207 | | of which CMBS | | 0 | | 171 | | 2 | | – | | – | | 173 | | of which equity securities | | 6 | | 119 | | 0 | | – | | – | | 125 | | Other investments | | 25 | | 16 | | 1,601 | | – | | 1,855 | | 3,497 | | of which private equity | | 0 | | 0 | | 29 | | – | | 343 | | 372 | | of which equity funds | | 0 | | 0 | | 22 | | – | | 133 | | 155 | | of which hedge funds | | 0 | | 0 | | 0 | | – | | 391 | | 391 | | of which debt funds | | 0 | | 0 | | 0 | | – | | 239 | | 239 | | of which other equity investments | | 25 | | 9 | | 271 | | – | | 1,121 | | 1,426 | | of which private | | 18 | | 9 | | 271 | | – | | 1,121 | | 1,419 | | of which life finance instruments | | 0 | | 7 | | 1,301 | | – | | – | | 1,308 | | Loans | | 0 | | 10,777 | | 4,530 | | – | | – | | 15,307 | | of which commercial and industrial loans | | 0 | | 3,437 | | 2,207 | | – | | – | | 5,644 | | of which financial institutions | | 0 | | 4,890 | | 1,480 | | – | | – | | 6,370 | | Other intangible assets (mortgage servicing rights) | | 0 | | 0 | | 158 | | – | | – | | 158 | | Other assets | | 101 | | 7,570 | | 1,511 | | (164) | | – | | 9,018 | | of which loans held-for-sale | | 0 | | 5,800 | | 1,350 | | – | | – | | 7,150 | | Total assets at fair value | | 124,525 | | 287,423 | | 16,642 | | (128,771) | | 2,908 | | 302,727 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis (continued)
end of 2017 | |
Level 1 | |
Level 2 | |
Level 3 | |
Netting
impact | 1 | Liabilities
measured
at net
asset value
per share | 2 |
Total | | Liabilities (CHF million) | Due to banks | | 0 | | 197 | | 0 | | – | | – | | 197 | | Customer deposits | | 0 | | 3,056 | | 455 | | – | | – | | 3,511 | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | 0 | | 15,262 | | 0 | | – | | – | | 15,262 | | Obligation to return securities received as collateral | | 36,697 | | 1,331 | | 46 | | – | | – | | 38,074 | | of which debt securities | | 576 | | 802 | | 0 | | – | | – | | 1,378 | | of which corporates | | 0 | | 726 | | 0 | | – | | – | | 726 | | of which equity securities | | 36,121 | | 529 | | 46 | | – | | – | | 36,696 | | Trading liabilities | | 23,121 | | 149,951 | | 3,226 | | (137,175) | | 9 | | 39,132 | | of which debt securities | | 5,160 | | 4,139 | | 2 | | – | | – | | 9,301 | | of which foreign governments | | 5,108 | | 746 | | 0 | | – | | – | | 5,854 | | of which corporates | | 12 | | 3,334 | | 2 | | – | | – | | 3,348 | | of which equity securities | | 14,230 | | 883 | | 55 | | – | | 9 | | 15,177 | | of which derivatives | | 3,731 | | 144,929 | | 3,169 | | (137,175) | | – | | 14,654 | | of which interest rate products | | 1,254 | | 80,290 | | 317 | | – | | – | | – | | of which foreign exchange products | | 8 | | 35,707 | | 100 | | – | | – | | – | | of which equity/index-related products | | 2,468 | | 20,017 | | 1,301 | | – | | – | | – | | of which credit derivatives | | 0 | | 7,982 | | 898 | | – | | – | | – | | Short-term borrowings | | 0 | | 10,174 | | 845 | | – | | – | | 11,019 | | Long-term debt | | 0 | | 50,121 | | 12,501 | | – | | – | | 62,622 | | of which treasury debt over two years | | 0 | | 936 | | 0 | | – | | – | | 936 | | of which structured notes over one year and up to two years | | 0 | | 6,216 | | 149 | | – | | – | | 6,365 | | of which structured notes over two years | | 0 | | 32,782 | | 12,259 | | – | | – | | 45,041 | | of which other debt instruments over two years | | 0 | | 2,221 | | 61 | | – | | – | | 2,282 | | of which other subordinated bonds | | 0 | | 4,557 | | 0 | | – | | – | | 4,557 | | of which non-recourse liabilities | | 0 | | 833 | | 30 | | – | | – | | 863 | | Other liabilities | | 0 | | 7,356 | | 1,467 | | (233) | | – | | 8,590 | | of which failed sales | | 0 | | 439 | | 223 | | – | | – | | 662 | | Total liabilities at fair value | | 59,818 | | 237,448 | | 18,540 | | (137,408) | | 9 | | 178,407 | | 1 Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements. | 2 In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. | Assets and liabilities measured at fair value on a recurring basis for level 3 | | | | | | | | | | | | | | | |
Trading revenues | |
Other revenues | | Accumulated other
comprehensive income | | | | | |
2018 | |
Balance at
beginning
of period | |
Transfers
in | |
Transfers
out | |
Purchases | |
Sales | |
Issuances | |
Settlements | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | | Foreign
currency
translation
impact | |
Balance
at end
of period | | Assets (CHF million) | Securities received as collateral | | 46 | | 0 | | (15) | | 102 | | (103) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 30 | | Trading assets | | 8,754 | | 1,563 | | (1,602) | | 40,057 | | (40,138) | | 1,394 | | (1,477) | | (21) | | 303 | | 0 | | 0 | | 0 | | 0 | | (19) | | 8,814 | | of which debt securities | | 2,292 | | 802 | | (904) | | 3,301 | | (3,261) | | 0 | | 0 | | 25 | | (150) | | 0 | | (3) | | 0 | | 0 | | (26) | | 2,076 | | of which foreign governments | | 270 | | 21 | | (12) | | 45 | | (67) | | 0 | | 0 | | 0 | | 4 | | 0 | | 0 | | 0 | | 0 | | (29) | | 232 | | of which corporates | | 1,412 | | 491 | | (593) | | 2,582 | | (2,583) | | 0 | | 0 | | 31 | | (72) | | 0 | | (4) | | 0 | | 0 | | (4) | | 1,260 | | of which RMBS | | 320 | | 211 | | (225) | | 370 | | (333) | | 0 | | 0 | | (3) | | (74) | | 0 | | 0 | | 0 | | 0 | | 3 | | 269 | | of which equity securities | | 163 | | 132 | | (95) | | 51 | | (185) | | 0 | | 0 | | 8 | | 55 | | 0 | | 3 | | 0 | | 0 | | 0 | | 132 | | of which derivatives | | 3,289 | | 510 | | (525) | | 0 | | 0 | | 1,394 | | (1,434) | | (56) | | 144 | | 0 | | 0 | | 0 | | 0 | | (24) | | 3,298 | | of which interest rate products | | 801 | | 18 | | (66) | | 0 | | 0 | | 100 | | (116) | | 17 | | (237) | | 0 | | 0 | | 0 | | 0 | | (10) | | 507 | | of which foreign exchange derivatives | | 188 | | 3 | | (2) | | 0 | | 0 | | 14 | | (24) | | (2) | | 79 | | 0 | | 0 | | 0 | | 0 | | 2 | | 258 | | of which equity/index-related products | | 833 | | 329 | | (317) | | 0 | | 0 | | 447 | | (436) | | (77) | | 300 | | 0 | | 0 | | 0 | | 0 | | (25) | | 1,054 | | of which credit derivatives | | 634 | | 160 | | (141) | | 0 | | 0 | | 505 | | (438) | | 5 | | (59) | | 0 | | 0 | | 0 | | 0 | | 7 | | 673 | | of which other derivatives | | 833 | | 0 | | 1 | | 0 | | 0 | | 328 | | (420) | | 1 | | 61 | | 0 | | 0 | | 0 | | 0 | | 2 | | 806 | | of which other trading assets | | 3,010 | | 119 | | (78) | | 36,705 | | (36,692) | | 0 | | (43) | | 2 | | 254 | | 0 | | 0 | | 0 | | 0 | | 31 | | 3,308 | | Investment securities | | 42 | | 8 | | (121) | | 281 | | (28) | | 0 | | (205) | | 0 | | 185 | | 0 | | 0 | | 0 | | 0 | | 4 | | 166 | | Other investments | | 1,601 | | 79 | | (102) | | 228 | | (405) | | 0 | | 0 | | 0 | | (93) | | 0 | | 5 | | 0 | | 0 | | (4) | | 1,309 | | of which life finance instruments | | 1,301 | | 0 | | 0 | | 151 | | (299) | | 0 | | 0 | | 0 | | (96) | | 0 | | 0 | | 0 | | 0 | | 10 | | 1,067 | | Loans | | 4,530 | | 934 | | (393) | | 163 | | (491) | | 1,563 | | (1,866) | | 7 | | (134) | | 0 | | (13) | | 0 | | 0 | | 24 | | 4,324 | | of which real estate | | 171 | | 196 | | (81) | | 0 | | 0 | | 307 | | (64) | | 2 | | (8) | | 0 | | (8) | | 0 | | 0 | | 0 | | 515 | | of which commercial and industrial loans | | 2,207 | | 348 | | (29) | | 1 | | (226) | | 783 | | (1,057) | | 0 | | (83) | | 0 | | (5) | | 0 | | 0 | | 10 | | 1,949 | | of which financial institutions | | 1,480 | | 335 | | (53) | | 150 | | (133) | | 332 | | (746) | | 10 | | 8 | | 0 | | 0 | | 0 | | 0 | | 8 | | 1,391 | | Other intangible assets (mortgage servicing rights) | | 158 | | 0 | | 0 | | 1 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 1 | | 0 | | 0 | | 3 | | 163 | | Other assets | | 1,511 | | 288 | | (191) | | 1,610 | | (1,357) | | 300 | | (540) | | 22 | | (32) | | 0 | | (1) | | 0 | | 0 | | (67) | | 1,543 | | of which loans held-for-sale | | 1,350 | | 243 | | (166) | | 1,447 | | (1,310) | | 300 | | (539) | | 21 | | (44) | | 0 | | 0 | | 0 | | 0 | | (67) | | 1,235 | | Total assets at fair value | | 16,642 | | 2,872 | | (2,424) | | 42,442 | | (42,522) | | 3,257 | | (4,088) | | 8 | | 229 | | 0 | | (8) | | 0 | | 0 | | (59) | | 16,349 | | Liabilities (CHF million) | Customer deposits | | 455 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 32 | | 0 | | 0 | | 0 | | (21) | | (13) | | 453 | | Obligation to return securities received as collateral | | 46 | | 0 | | (15) | | 102 | | (103) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 30 | | Trading liabilities | | 3,226 | | 768 | | (641) | | 127 | | (107) | | 2,573 | | (1,527) | | (7) | | (839) | | 0 | | (3) | | 0 | | 0 | | 19 | | 3,589 | | of which debt securities | | 2 | | 30 | | (24) | | 39 | | (23) | | 0 | | 0 | | 0 | | 1 | | 0 | | 0 | | 0 | | 0 | | 0 | | 25 | | of which equity securities | | 55 | | 19 | | (5) | | 87 | | (80) | | 0 | | 0 | | (3) | | (33) | | 0 | | (3) | | 0 | | 0 | | 0 | | 37 | | of which derivatives | | 3,169 | | 719 | | (612) | | 1 | | (4) | | 2,573 | | (1,527) | | (4) | | (807) | | 0 | | 0 | | 0 | | 0 | | 19 | | 3,527 | | of which interest rate derivatives | | 317 | | 25 | | (11) | | 0 | | 0 | | 156 | | (145) | | 16 | | (171) | | 0 | | 0 | | 0 | | 0 | | 2 | | 189 | | of which foreign exchange derivatives | | 100 | | 19 | | (1) | | 0 | | 0 | | 55 | | (29) | | 0 | | 15 | | 0 | | 0 | | 0 | | 0 | | 1 | | 160 | | of which equity/index-related derivatives | | 1,301 | | 429 | | (364) | | 0 | | 0 | | 1,306 | | (548) | | (36) | | (592) | | 0 | | 0 | | 0 | | 0 | | 4 | | 1,500 | | of which credit derivatives | | 898 | | 247 | | (235) | | 0 | | 0 | | 806 | | (572) | | 16 | | (30) | | 0 | | 0 | | 0 | | 0 | | 10 | | 1,140 | | Short-term borrowings | | 845 | | 335 | | (242) | | 0 | | 0 | | 1,090 | | (1,133) | | 3 | | (117) | | 0 | | (4) | | 0 | | 0 | | 7 | | 784 | | Long-term debt | | 12,501 | | 2,873 | | (3,108) | | 0 | | 0 | | 5,761 | | (3,656) | | (25) | | (1,381) | | 0 | | 0 | | (2) | | (417) | | 125 | | 12,671 | | of which structured notes over one year and up to two years | | 149 | | 452 | | (296) | | 0 | | 0 | | 745 | | (501) | | (10) | | (14) | | 0 | | 0 | | 0 | | 0 | | 3 | | 528 | | of which structured notes over two years | | 12,259 | | 2,368 | | (2,800) | | 0 | | 0 | | 4,761 | | (3,115) | | (17) | | (1,355) | | 0 | | 0 | | (2) | | (417) | | 118 | | 11,800 | | Other liabilities | | 1,467 | | 117 | | (29) | | 45 | | (128) | | 20 | | (417) | | (7) | | 94 | | 0 | | 159 | | 0 | | 0 | | 6 | | 1,327 | | Total liabilities at fair value | | 18,540 | | 4,093 | | (4,035) | | 274 | | (338) | | 9,444 | | (6,733) | | (36) | | (2,211) | | 0 | | 152 | | (2) | | (438) | | 144 | | 18,854 | | Net assets/(liabilities) at fair value | | (1,898) | | (1,221) | | 1,611 | | 42,168 | | (42,184) | | (6,187) | | 2,645 | | 44 | | 2,440 | | 0 | | (160) | | 2 | | 438 | | (203) | | (2,505) | | Assets and liabilities measured at fair value on a recurring basis for level 3 (continued) | | | | | | | | | | | | | | | |
Trading revenues | |
Other revenues | | Accumulated other
comprehensive income | | | | | |
2017 | |
Balance at
beginning
of period | |
Transfers
in | |
Transfers
out | |
Purchases | |
Sales | |
Issuances | |
Settlements | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | |
On
transfers
in / out | |
On
all
other | | Foreign
currency
translation
impact | |
Balance
at end
of period | | Assets (CHF million) | Interest-bearing deposits with banks | | 1 | | 40 | | 0 | | 0 | | (41) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 174 | | 0 | | 0 | | 0 | | 0 | | 26 | | (193) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | (7) | | 0 | | Securities received as collateral | | 70 | | 3 | | (1) | | 65 | | (86) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | (5) | | 46 | | Trading assets | | 12,765 | | 1,159 | | (2,046) | | 15,810 | | (18,032) | | 1,317 | | (2,068) | | 121 | | 252 | | 6 | | 1 | | 0 | | 0 | | (531) | | 8,754 | | of which debt securities | | 3,977 | | 608 | | (1,074) | | 2,747 | | (3,705) | | 0 | | 0 | | (4) | | (80) | | 6 | | 1 | | 0 | | 0 | | (184) | | 2,292 | | of which corporates | | 1,674 | | 276 | | (654) | | 2,203 | | (2,005) | | 0 | | 0 | | (4) | | 14 | | 6 | | 0 | | 0 | | 0 | | (98) | | 1,412 | | of which RMBS | | 605 | | 280 | | (229) | | 85 | | (305) | | 0 | | 0 | | 3 | | (95) | | 0 | | 0 | | 0 | | 0 | | (24) | | 320 | | of which CMBS | | 65 | | 6 | | (17) | | 2 | | (13) | | 0 | | 0 | | (3) | | (21) | | 0 | | 0 | | 0 | | 0 | | (3) | | 16 | | of which CDO | | 1,165 | | 39 | | (157) | | 174 | | (1,047) | | 0 | | 0 | | 0 | | (16) | | 0 | | 0 | | 0 | | 0 | | (32) | | 126 | | of which equity securities | | 240 | | 49 | | (35) | | 146 | | (260) | | 0 | | 0 | | 0 | | 33 | | 0 | | 0 | | 0 | | 0 | | (10) | | 163 | | of which derivatives | | 4,305 | | 416 | | (839) | | 0 | | 0 | | 1,317 | | (1,817) | | 123 | | (63) | | 0 | | 0 | | 0 | | 0 | | (153) | | 3,289 | | of which interest rate products | | 748 | | 56 | | (53) | | 0 | | 0 | | 118 | | (183) | | 6 | | 104 | | 0 | | 0 | | 0 | | 0 | | 5 | | 801 | | of which equity/index-related products | | 914 | | 142 | | (98) | | 0 | | 0 | | 443 | | (597) | | 14 | | 58 | | 0 | | 0 | | 0 | | 0 | | (43) | | 833 | | of which credit derivatives | | 688 | | 216 | | (252) | | 0 | | 0 | | 381 | | (297) | | 38 | | (110) | | 0 | | 0 | | 0 | | 0 | | (30) | | 634 | | of which other trading assets | | 4,243 | | 86 | | (98) | | 12,917 | | (14,067) | | 0 | | (251) | | 2 | | 362 | | 0 | | 0 | | 0 | | 0 | | (184) | | 3,010 | | Investment securities | | 72 | | 0 | | (17) | | 100 | | (113) | | 0 | | (90) | | (1) | | 95 | | 0 | | 0 | | 0 | | 0 | | (4) | | 42 | | Other investments | | 1,906 | | 23 | | (22) | | 324 | | (562) | | 0 | | 0 | | 0 | | 9 | | 0 | | 9 | | 0 | | 0 | | (86) | | 1,601 | | of which equity | | 318 | | 23 | | (22) | | 139 | | (144) | | 0 | | 0 | | 0 | | (7) | | 0 | | 9 | | 0 | | 0 | | (16) | | 300 | | of which life finance instruments | | 1,588 | | 0 | | 0 | | 185 | | (418) | | 0 | | 0 | | 0 | | 16 | | 0 | | 0 | | 0 | | 0 | | (70) | | 1,301 | | Loans | | 6,585 | | 1,130 | | (947) | | 106 | | (580) | | 1,151 | | (2,743) | | 15 | | 85 | | 0 | | 0 | | 0 | | 0 | | (272) | | 4,530 | | of which commercial and industrial loans | | 3,816 | | 448 | | (482) | | 71 | | (395) | | 590 | | (1,705) | | (2) | | 21 | | 0 | | 0 | | 0 | | 0 | | (155) | | 2,207 | | of which financial institutions | | 1,829 | | 352 | | (126) | | 33 | | (176) | | 444 | | (821) | | 28 | | (6) | | 0 | | 0 | | 0 | | 0 | | (77) | | 1,480 | | Other intangible assets (mortgage servicing rights) | | 138 | | 0 | | 0 | | 23 | | (1) | | 0 | | 0 | | 0 | | 0 | | 0 | | 4 | | 0 | | 0 | | (6) | | 158 | | Other assets | | 1,679 | | 347 | | (132) | | 759 | | (1,056) | | 1,054 | | (885) | | (1) | | (172) | | 0 | | (4) | | 0 | | 0 | | (78) | | 1,511 | | of which loans held-for-sale | | 1,316 | | 286 | | (113) | | 667 | | (904) | | 1,053 | | (885) | | (2) | | 0 | | 0 | | (4) | | 0 | | 0 | | (64) | | 1,350 | | Total assets at fair value | | 23,390 | | 2,702 | | (3,165) | | 17,187 | | (20,471) | | 3,548 | | (5,979) | | 134 | | 269 | | 6 | | 10 | | 0 | | 0 | | (989) | | 16,642 | | Liabilities (CHF million) | Customer deposits | | 410 | | 0 | | 0 | | 0 | | 0 | | 35 | | (3) | | 0 | | (61) | | 0 | | 0 | | 0 | | 42 | | 32 | | 455 | | Obligation to return securities received as collateral | | 70 | | 3 | | (1) | | 65 | | (86) | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | 0 | | (5) | | 46 | | Trading liabilities | | 3,737 | | 566 | | (1,049) | | 113 | | (134) | | 1,193 | | (1,625) | | 140 | | 461 | | 0 | | (9) | | 0 | | 0 | | (167) | | 3,226 | | of which interest rate derivatives | | 538 | | 57 | | (36) | | 0 | | 0 | | 45 | | (258) | | 6 | | (14) | | 0 | | 0 | | 0 | | 0 | | (21) | | 317 | | of which foreign exchange derivatives | | 150 | | 11 | | (1) | | 0 | | 0 | | 9 | | (12) | | 0 | | (52) | | 0 | | 0 | | 0 | | 0 | | (5) | | 100 | | of which equity/index-related derivatives | | 1,181 | | 54 | | (188) | | 0 | | 0 | | 543 | | (692) | | 17 | | 441 | | 0 | | 0 | | 0 | | 0 | | (55) | | 1,301 | | of which credit derivatives | | 851 | | 377 | | (392) | | 0 | | 0 | | 350 | | (376) | | 61 | | 66 | | 0 | | 0 | | 0 | | 0 | | (39) | | 898 | | Short-term borrowings | | 516 | | 95 | | (172) | | 0 | | 0 | | 865 | | (472) | | (2) | | 19 | | 4 | | 10 | | 0 | | 6 | | (24) | | 845 | | Long-term debt | | 13,415 | | 1,172 | | (3,004) | | 0 | | 0 | | 4,540 | | (4,479) | | (12) | | 1,400 | | 0 | | 0 | | 88 | | 21 | | (640) | | 12,501 | | of which structured notes over two years | | 12,434 | | 995 | | (2,886) | | 0 | | 0 | | 3,913 | | (3,079) | | (14) | | 1,390 | | 0 | | 0 | | 87 | | 17 | | (598) | | 12,259 | | Other liabilities | | 1,679 | | 150 | | (102) | | 211 | | (304) | | 7 | | (398) | | (25) | | (8) | | 0 | | 327 | | 0 | | 0 | | (70) | | 1,467 | | of which failed sales | | 219 | | 80 | | (70) | | 189 | | (218) | | 0 | | 0 | | (7) | | 40 | | 0 | | 0 | | 0 | | 0 | | (10) | | 223 | | Total liabilities at fair value | | 19,827 | | 1,986 | | (4,328) | | 389 | | (524) | | 6,640 | | (6,977) | | 101 | | 1,811 | | 4 | | 328 | | 88 | | 69 | | (874) | | 18,540 | | Net assets/(liabilities) at fair value | | 3,563 | | 716 | | 1,163 | | 16,798 | | (19,947) | | (3,092) | | 998 | | 33 | | (1,542) | | 2 | | (318) | | (88) | | (69) | | (115) | | (1,898) | | Gains and losses on assets and liabilities measured at fair value on a recurring basis (level 3) | | 2018 | | 2017 | |
in | | Trading
revenues | | Other
revenues | | Total
revenues | | Trading
revenues | | Other
revenues | | Total
revenues | | Gains and losses on assets and liabilities (CHF million) | Net realized/unrealized gains/(losses) included in net revenues | | 2,484 | | (160) | | 2,324 | 1 | (1,509) | | (316) | | (1,825) | 1 | Whereof: | | | | | | | | | | | | | | Unrealized gains/(losses) relating to assets and liabilities still held as of the reporting date | | (35) | | (6) | | (41) | | (2,088) | | 20 | | (2,068) | | 1 Excludes net realized/unrealized gains/(losses) attributable to foreign currency translation impact. | Quantitative information about level 3 assets at fair value
end of 2018 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Securities received as collateral | | 30 | | – | | – | | – | | – | | – | | Trading assets | | 8,814 | | | | | | | | | | | | of which debt securities | | 2,076 | | | | | | | | | | | | of which foreign governments | | 232 | | Discounted cash flow | | Credit spread, in bp | | 140 | | 140 | | 140 | | of which corporates | | 1,260 | | | | | | | | | | | | of which | | 441 | | Market comparable | | Price, in % | | 0 | | 118 | | 94 | | of which | | 621 | | Option model | | Correlation, in % | | (60) | | 98 | | 68 | | | | | | | | Volatility, in % | | 0 | | 178 | | 30 | | of which RMBS | | 269 | | Discounted cash flow | | Default rate, in % | | 0 | | 11 | | 3 | | | | | | | | Discount rate, in % | | 1 | | 26 | | 7 | | | | | | | | Loss severity, in % | | 0 | | 100 | | 63 | | | | | | | | Prepayment rate, in % | | 1 | | 22 | | 8 | | of which equity securities | | 132 | | | | | | | | | | | | of which | | 76 | | Market comparable | | EBITDA multiple | | 2 | | 9 | | 6 | | | | | | | | Price, in % | | 100 | | 100 | | 100 | | of which | | 49 | | Vendor price | | Price, in actuals | | 0 | | 355 | | 1 | | of which derivatives | | 3,298 | | | | | | | | | | | | of which interest rate products | | 507 | | Option model | | Correlation, in % | | 0 | | 100 | | 69 | | | | | | | | Prepayment rate, in % | | 1 | | 26 | | 9 | | | | | | | | Volatility skew, in % | | (4) | | 0 | | (2) | | of which foreign exchange products | | 258 | | | | | | | | | | | | of which | | 28 | | Discounted cash flow | | Contingent probability, in % | | 95 | | 95 | | 95 | | of which | | 218 | | Option model | | Correlation, in % | | (23) | | 70 | | 24 | | | | | | | | Prepayment rate, in % | | 21 | | 26 | | 23 | | | | | | | | Volatility, in % | | 80 | | 90 | | 85 | | of which equity/index-related products | | 1,054 | | Option model | | Buyback probability, in % | | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (40) | | 98 | | 80 | | | | | | | | Gap risk, in % | 2 | 0 | | 4 | | 1 | | | | | | | | Volatility, in % | | 2 | | 178 | | 34 | | of which credit derivatives | | 673 | | Discounted cash flow | | Correlation, in % | | 97 | | 97 | | 97 | | | | | | | | Credit spread, in bp | | 3 | | 2,147 | | 269 | | | | | | | | Default rate, in % | | 1 | | 20 | | 4 | | | | | | | | Discount rate, in % | | 3 | | 28 | | 15 | | | | | | | | Loss severity, in % | | 16 | | 85 | | 56 | | | | | | | | Prepayment rate, in % | | 0 | | 12 | | 6 | | | | | | | | Recovery rate, in % | | 0 | | 68 | | 8 | | of which other derivatives | | 806 | | Discounted cash flow | | Market implied life expectancy, in years | | 2 | | 16 | | 5 | | | | | | | | Mortality rate, in % | | 87 | | 106 | | 101 | | of which other trading assets | | 3,308 | | | | | | | | | | | | of which | | 870 | | Discounted cash flow | | Market implied life expectancy, in years | | 3 | | 17 | | 7 | | of which | | 2,119 | | Market comparable | | Price, in % | | 0 | | 110 | | 30 | | of which | | 249 | | Option model | | Mortality rate, in % | | 0 | | 70 | | 6 | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | Quantitative information about level 3 assets at fair value (continued)
end of 2018 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Investment securities | | 166 | | – | | – | | – | | – | | – | | Other investments | | 1,309 | | | | | | | | | | | | of which life finance instruments | | 1,067 | | Discounted cash flow | | Market implied life expectancy, in years | | 2 | | 17 | | 6 | | Loans | | 4,324 | | | | | | | | | | | | of which real estate | | 515 | | Discounted cash flow | | Credit spread, in bp | | 200 | | 1,522 | | 612 | | | | | | | | Recovery rate, in % | | 25 | | 40 | | 39 | | of which commercial and industrial loans | | 1,949 | | | | | | | | | | | | of which | | 1,531 | | Discounted cash flow | | Credit spread, in bp | | 159 | | 1,184 | | 582 | | of which | | 306 | | Market comparable | | Price, in % | | 0 | | 99 | | 65 | | of which financial institutions | | 1,391 | | | | | | | | | | | | of which | | 1,157 | | Discounted cash flow | | Credit spread, in bp | | 88 | | 1,071 | | 596 | | of which | | 73 | | Market comparable | | Price, in % | | 1 | | 100 | | 74 | | Other intangible assets (mortgage servicing rights) | | 163 | | – | | – | | – | | – | | – | | Other assets | | 1,543 | | | | | | | | | | | | of which loans held-for-sale | | 1,235 | | | | | | | | | | | | of which | | 422 | | Discounted cash flow | | Credit spread, in bp | | 105 | | 2,730 | | 394 | | | | | | | | Recovery rate, in % | | 25 | | 87 | | 56 | | of which | | 739 | | Market comparable | | Price, in % | | 0 | | 130 | | 82 | | Total level 3 assets at fair value | | 16,349 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | Quantitative information about level 3 assets at fair value (continued)
end of 2017 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Securities received as collateral | | 46 | | – | | – | | – | | – | | – | | Trading assets | | 8,754 | | | | | | | | | | | | of which debt securities | | 2,292 | | | | | | | | | | | | of which corporates | | 1,412 | | | | | | | | | | | | of which | | 387 | | Option model | | Correlation, in % | | (60) | | 98 | | 55 | | of which | | 545 | | Market comparable | | Price, in % | | 0 | | 139 | | 84 | | of which | | 444 | | Discounted cash flow | | Credit spread, in bp | | 37 | | 952 | | 230 | | of which RMBS | | 320 | | Discounted cash flow | | Discount rate, in % | | 1 | | 24 | | 11 | | | | | | | | Prepayment rate, in % | | 1 | | 36 | | 10 | | | | | | | | Default rate, in % | | 0 | | 12 | | 4 | | | | | | | | Loss severity, in % | | 0 | | 100 | | 57 | | of which CMBS | | 16 | | Discounted cash flow | | Capitalization rate, in % | | 14 | | 14 | | 14 | | | | | | | | Discount rate, in % | | 8 | | 16 | | 14 | | | | | | | | Prepayment rate, in % | | 0 | | 5 | | 4 | | of which CDO | | 126 | | Discounted cash flow | | Discount rate, in % | | 5 | | 13 | | 8 | | | | | | | | Prepayment rate, in % | | 5 | | 20 | | 13 | | | | | | | | Credit spread, in bp | | 464 | | 669 | | 553 | | | | | | | | Default rate, in % | | 2 | | 5 | | 3 | | | | | | | | Loss severity, in % | | 0 | | 80 | | 34 | | of which equity securities | | 163 | | | | | | | | | | | | of which | | 67 | | Vendor price | | Price, in actuals | | 0 | | 2,080 | | 10 | | of which | | 81 | | Market comparable | | EBITDA multiple | | 2 | | 9 | | 7 | | | | | | | | Price, in % | | 18 | | 100 | | 67 | | of which derivatives | | 3,289 | | | | | | | | | | | | of which interest rate products | | 801 | | Option model | | Correlation, in % | | 20 | | 100 | | 72 | | | | | | | | Prepayment rate, in % | | 6 | | 34 | | 17 | | | | | | | | Volatility skew, in % | | (4) | | 1 | | (1) | | of which equity/index-related products | | 833 | | Option model | | Correlation, in % | | (60) | | 98 | | 65 | | | | | | | | Volatility, in % | | 0 | | 105 | | 64 | | | | | | | | Buyback probability, in % | | 50 | | 100 | | 90 | | | | | | | | Gap risk, in % | 2 | 0 | | 2 | | 1 | | of which credit derivatives | | 634 | | Discounted cash flow | | Credit spread, in bp | | 1 | | 956 | | 217 | | | | | | | | Recovery rate, in % | | 0 | | 45 | | 20 | | | | | | | | Discount rate, in % | | 3 | | 50 | | 16 | | | | | | | | Default rate, in % | | 1 | | 20 | | 5 | | | | | | | | Loss severity, in % | | 1 | | 100 | | 64 | | | | | | | | Correlation, in % | | 97 | | 97 | | 97 | | | | | | | | Prepayment rate, in % | | 0 | | 14 | | 6 | | of which other trading assets | | 3,010 | | | | | | | | | | | | of which | | 1,605 | | Market comparable | | Price, in % | | 0 | | 110 | | 23 | | of which | | 1,095 | | Discounted cash flow | | Market implied life expectancy, in years | | 3 | | 18 | | 8 | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | Quantitative information about level 3 assets at fair value (continued)
end of 2017 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Investment securities | | 42 | | – | | – | | – | | – | | – | | Other investments | | 1,601 | | | | | | | | | | | | of which private equity | | 29 | | – | | – | | – | | – | | – | | of which other equity investments | | 271 | | – | | – | | – | | – | | – | | of which life finance instruments | | 1,301 | | Discounted cash flow | | Market implied life expectancy, in years | | 2 | | 18 | | 6 | | Loans | | 4,530 | | | | | | | | | | | | of which commercial and industrial loans | | 2,207 | | | | | | | | | | | | of which | | 1,924 | | Discounted cash flow | | Credit spread, in bp | | 89 | | 1,116 | | 420 | | of which | | 250 | | Market comparable | | Price, in % | | 0 | | 99 | | 56 | | of which financial institutions | | 1,480 | | | | | | | | | | | | of which | | 1,426 | | Discounted cash flow | | Credit spread, in bp | | 43 | | 1,430 | | 371 | | Other intangible assets (mortgage servicing rights) | | 158 | | – | | – | | – | | – | | – | | Other assets | | 1,511 | | | | | | | | | | | | of which loans held-for-sale | | 1,350 | | | | | | | | | | | | of which | | 849 | | Discounted cash flow | | Credit spread, in bp | | 117 | | 973 | | 292 | | | | | | | | Recovery rate, in % | | 18 | | 87 | | 73 | | of which | | 280 | | Market comparable | | Price, in % | | 0 | | 102 | | 88 | | Total level 3 assets at fair value | | 16,642 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | Quantitative information about level 3 liabilities at fair value
end of 2018 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Customer deposits | | 453 | | – | | – | | – | | – | | – | | Obligation to return securities received as collateral | | 30 | | – | | – | | – | | – | | – | | Trading liabilities | | 3,589 | | | | | | | | | | | | of which debt securities | | 25 | | – | | – | | – | | – | | – | | of which equity securities | | 37 | | Vendor price | | Price, in actuals | | 0 | | 3 | | 0 | | of which derivatives | | 3,527 | | | | | | | | | | | | of which interest rate derivatives | | 189 | | Option model | | Basis spread, in bp | | (20) | | 147 | | 48 | | | | | | | | Correlation, in % | | 1 | | 100 | | 41 | | | | | | | | Prepayment rate, in % | | 1 | | 26 | | 7 | | of which foreign exchange derivatives | | 160 | | | | | | | | | | | | of which | | 62 | | Discounted cash flow | | Contingent probability, in % | | 95 | | 95 | | 95 | | | | | | | | Credit spread, in bp | | 146 | | 535 | | 379 | | of which | | 37 | | Market comparable | | Price, in % | | 100 | | 100 | | 100 | | of which | | 57 | | Option model | | Correlation, in % | | 35 | | 70 | | 53 | | | | | | | | Prepayment rate, in % | | 21 | | 26 | | 23 | | of which equity/index-related derivatives | | 1,500 | | Option model | | Buyback probability, in % | 2 | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (60) | | 98 | | 74 | | | | | | | | Volatility, in % | | 0 | | 178 | | 30 | | of which credit derivatives | | 1,140 | | | | | | | | | | | | of which | | 566 | | Discounted cash flow | | Correlation, in % | | 38 | | 82 | | 47 | | | | | | | | Credit spread, in bp | | 3 | | 2,937 | | 262 | | | | | | | | Default rate, in % | | 1 | | 20 | | 4 | | | | | | | | Discount rate, in % | | 3 | | 28 | | 14 | | | | | | | | Loss severity, in % | | 16 | | 95 | | 56 | | | | | | | | Prepayment rate, in % | | 0 | | 12 | | 6 | | | | | | | | Recovery rate, in % | | 0 | | 80 | | 14 | | of which | | 508 | | Market comparable | | Price, in % | | 75 | | 104 | | 89 | | of which | | 20 | | Option model | | Correlation, in % | | 50 | | 50 | | 50 | | | | | | | | Credit spread, in bp | | 35 | | 1,156 | | 320 | | Short-term borrowings | | 784 | | | | | | | | | | | | of which | | 61 | | Discounted cash flow | | Credit spread, in bp | | 1,018 | | 1,089 | | 1,067 | | | | | | | | Recovery rate, in % | | 40 | | 40 | | 40 | | of which | | 644 | | Option model | | Buyback probability, in % | | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (40) | | 98 | | 64 | | | | | | | | Fund gap risk, in % | 3 | 0 | | 4 | | 1 | | | | | | | | Volatility, in % | | 2 | | 178 | | 32 | | Long-term debt | | 12,671 | | | | | | | | | | | | of which structured notes over one year and up to two years | | 528 | | | | | | | | | | | | of which | | 3 | | Discounted cash flow | | Credit spread, in bp | | 112 | | 112 | | 112 | | of which | | 427 | | Option model | | Correlation, in % | | (40) | | 98 | | 71 | | | | | | | | Volatility, in % | | 2 | | 178 | | 31 | | of which structured notes over two years | | 11,800 | | | | | | | | | | | | of which | | 1,570 | | Discounted cash flow | | Credit spread, in bp | | (11) | | 1,089 | | 136 | | of which | | 43 | | Market comparable | | Price, in % | | 0 | | 46 | | 30 | | of which | | 9,533 | | Option model | | Buyback probability, in % | 2 | 50 | | 100 | | 74 | | | | | | | | Correlation, in % | | (60) | | 98 | | 65 | | | | | | | | Gap risk, in % | 3 | 0 | | 4 | | 1 | | | | | | | | Mean reversion, in % | 4 | (55) | | (1) | | (7) | | | | | | | | Volatility, in % | | 0 | | 178 | | 27 | | Other liabilities | | 1,327 | | – | | – | | – | | – | | – | | Total level 3 liabilities at fair value | | 18,854 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Estimate of the probability of structured notes being put back to the Bank at the option of the investor over the remaining life of the financial instruments. | 3 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | 4 Management's best estimate of the speed at which interest rates will revert to the long-term average. | Quantitative information about level 3 liabilities at fair value (continued)
end of 2017 | |
Fair value | | Valuation
technique | | Unobservable
input | | Minimum
value | | Maximum
value | | Weighted
average | 1 | CHF million, except where indicated | Customer deposits | | 455 | | – | | – | | – | | – | | – | | Obligation to return securities received as collateral | | 46 | | – | | – | | – | | – | | – | | Trading liabilities | | 3,226 | | | | | | | | | | | | of which interest rate derivatives | | 317 | | | | | | | | | | | | of which | | 205 | | Option model | | Basis spread, in bp | | (25) | | 52 | | 19 | | | | | | | | Correlation, in % | | 20 | | 100 | | 60 | | | | | | | | Prepayment rate, in % | | 6 | | 34 | | 9 | | of which | | 81 | | Market comparable | | Price, in % | | 1 | | 102 | | 44 | | of which foreign exchange derivatives | | 100 | | | | | | | | | | | | of which | | 64 | | Option model | | Correlation, in % | | (10) | | 70 | | 51 | | | | | | | | Prepayment rate, in % | | 27 | | 34 | | 30 | | of which | | 7 | | Discounted cash flow | | Contingent probability, in % | | 95 | | 95 | | 95 | | of which equity/index-related derivatives | | 1,301 | | | | | | | | | | | | of which | | 947 | | Option model | | Correlation, in % | | (60) | | 98 | | 55 | | | | | | | | Volatility, in % | | 0 | | 105 | | 25 | | | | | | | | Buyback probability, in % | 2 | 50 | | 100 | | 90 | | of which | | 62 | | Vendor price | | Price, in actuals | | 0 | | 53 | | 18 | | of which credit derivatives | | 898 | | Discounted cash flow | | Credit spread, in bp | | 2 | | 973 | | 172 | | | | | | | | Discount rate, in % | | 3 | | 50 | | 16 | | | | | | | | Default rate, in % | | 1 | | 20 | | 5 | | | | | | | | Recovery rate, in % | | 10 | | 60 | | 38 | | | | | | | | Loss severity, in % | | 25 | | 100 | | 67 | | | | | | | | Correlation, in % | | 38 | | 85 | | 54 | | | | | | | | Prepayment rate, in % | | 0 | | 20 | | 7 | | | | | | | | Term TRS/repo spread, in bp | | 176 | | 176 | | 176 | | Short-term borrowings | | 845 | | | | | | | | | | | | of which | | 288 | | Option model | | Correlation, in % | | (40) | | 98 | | 60 | | | | | | | | Volatility, in % | | 4 | | 105 | | 26 | | of which | | 527 | | Discounted cash flow | | Credit spread, in bp | | 2 | | 278 | | 175 | | | | | | | | Recovery rate, in % | | 25 | | 40 | | 29 | | of which | | 24 | | Market comparable | | Price, in % | | 11 | | 47 | | 47 | | Long-term debt | | 12,501 | | | | | | | | | | | | of which structured notes over two years | | 12,259 | | | | | | | | | | | | of which | | 9,739 | | Option model | | Correlation, in % | | (60) | | 99 | | 55 | | | | | | | | Volatility, in % | | 0 | | 105 | | 21 | | | | | | | | Buyback probability, in % | 2 | 50 | | 100 | | 90 | | | | | | | | Gap risk, in % | 3 | 0 | | 2 | | 1 | | | | | | | | Mean reversion, in % | 4 | (14) | | (1) | | (6) | | of which | | 1,571 | | Discounted cash flow | | Credit spread, in bp | | 2 | | 729 | | 105 | | Other liabilities | | 1,467 | | | | | | | | | | | | of which failed sales | | 223 | | | | | | | | | | | | of which | | 122 | | Market comparable | | Price, in % | | 0 | | 100 | | 51 | | of which | | 25 | | Discounted cash flow | | Credit spread, in bp | | 1,430 | | 1,430 | | 1,430 | | Total level 3 liabilities at fair value | | 18,540 | | | | | | | | | | | | 1 Cash instruments are generally presented on a weighted average basis, while certain derivative instruments either contain a combination of weighted averages and arithmetic means of the related inputs or are presented on an arithmetic mean basis. | 2 Estimate of the probability of structured notes being put back to the Bank at the option of the investor over the remaining life of the financial instruments. | 3 Risk of unexpected large declines in the underlying values occurring between collateral settlement dates. | 4 Management's best estimate of the speed at which interest rates will revert to the long-term average. | Fair value, unfunded commitments and term of redemption conditions of investment funds measured at NAV per share | | 2018 | | 2017 | |
end of | |
Non-
redeemable | |
Redeemable | |
Total
fair value | | Unfunded
commit-
ments | |
Non-
redeemable | |
Redeemable | |
Total
fair value | | Unfunded
commit-
ments | | Fair value of investment funds and unfunded commitments (CHF million) | Debt funds | | 12 | | 0 | | 12 | | 0 | | 0 | | 0 | | 0 | | 0 | | Equity funds | | 103 | | 1,011 | 1 | 1,114 | | 53 | | 61 | | 992 | 2 | 1,053 | | 0 | | Equity funds sold short | | (8) | | (2) | | (10) | | 0 | | 0 | | (9) | | (9) | | 0 | | Funds held in trading assets and trading liabilities | | 107 | | 1,009 | | 1,116 | | 53 | | 61 | | 983 | | 1,044 | | 0 | | Debt funds | | 1 | | 0 | | 1 | | 0 | | 1 | | 0 | | 1 | | 0 | | Equity funds | | 126 | | 0 | | 126 | | 42 | | 133 | | 0 | | 133 | | 63 | | Real estate funds | | 214 | | 0 | | 214 | | 34 | | 178 | | 0 | | 178 | | 44 | | Other private equity funds | | 24 | | 5 | | 29 | | 29 | | 31 | | 0 | | 31 | | 16 | | Private equity funds | | 365 | | 5 | | 370 | | 105 | | 343 | | 0 | | 343 | | 123 | | Debt funds | | 68 | | 34 | | 102 | | 0 | | 164 | | 75 | | 239 | | 0 | | Equity funds | | 14 | | 14 | | 28 | | 0 | | 2 | | 53 | | 55 | | 0 | | Other hedge funds | | 2 | | 24 | | 26 | | 0 | | 2 | | 95 | | 97 | | 9 | | Hedge funds | | 84 | | 72 | 3 | 156 | | 0 | | 168 | | 223 | 4 | 391 | | 9 | | Equity method investment funds | | 52 | | 522 | | 574 | | 21 | | 71 | | 1,050 | | 1,121 | | 5 | | Funds held in other investments | | 501 | | 599 | | 1,100 | | 126 | | 582 | | 1,273 | | 1,855 | | 137 | | Fair value of investment funds and unfunded commitments | | 608 | 5 | 1,608 | | 2,216 | | 179 | 7 | 643 | 5 | 2,256 | 6 | 2,899 | | 137 | 7 | 1 46% of the redeemable fair value amount of equity funds is redeemable on demand with a notice period primarily of less than 30 days, 40% is redeemable on a monthly basis with a notice period primarily of more than 30 days, 13% is redeemable on a quarterly basis with a notice period primarily of more than 45 days and 1% is redeemable on an annual basis with a notice period primarily of less than 30 days. | 2 54% of the redeemable fair value amount of equity funds is redeemable on demand with a notice period primarily of less than 30 days, 35% is redeemable on a monthly basis with a notice period primarily of less than 30 days, 9% is redeemable on a quarterly basis with a notice period primarily of more than 45 days and 2% is redeemable on an annual basis with a notice period primarily of more than 60 days. | 3 65% of the redeemable fair value amount of hedge funds is redeemable on a quarterly basis with a notice period primarily of more than 60 days and 35% is redeemable on demand with a notice period primarily of less than 30 days. | 4 51% of the redeemable fair value amount of hedge funds is redeemable on a quarterly basis with a notice period primarily of more than 45 days, 43% is redeemable on a monthly basis with a notice period primarily of less than 30 days and 6% is redeemable on demand with a notice period primarily of less than 30 days. | 5 Includes CHF 102 million and CHF 229 million attributable to noncontrolling interests as of the end of 2018 and 2017, respectively. | 6 Includes CHF 167 million attributable to noncontrolling interests as of the end of 2017. | 7 Includes CHF 23 million and CHF 53 million attributable to noncontrolling interests as of the end of 2018 and 2017, respectively. | Assets measured at fair value on a nonrecurring basis end of | | 2018 | | 2017 | | Assets held-for-sale recorded at fair value on a nonrecurring basis (CHF billion) | Assets held-for-sale recorded at fair value on a nonrecurring basis | | 0.0 | | 0.1 | | of which level 2 | | 0.0 | | 0.1 | | Difference between the aggregate fair value and the unpaid principal balances of fair value option-elected financial instruments | | 2018 | | 2017 | |
end of | | Aggregate
fair
value | | Aggregate
unpaid
principal | |
Difference | | Aggregate
fair
value | | Aggregate
unpaid
principal | |
Difference | | Financial instruments (CHF million) | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 81,818 | | 81,637 | | 181 | | 77,498 | | 76,643 | | 855 | | Loans | | 14,873 | | 15,441 | | (568) | | 15,307 | | 15,372 | | (65) | | Other assets 1 | | 6,706 | | 9,240 | | (2,534) | | 8,468 | | 10,910 | | (2,442) | | Due to banks and customer deposits | | (859) | | (778) | | (81) | | (907) | | (861) | | (46) | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | (14,828) | | (14,827) | | (1) | | (15,262) | | (15,180) | | (82) | | Short-term borrowings | | (8,068) | | (8,647) | | 579 | | (11,019) | | (11,104) | | 85 | | Long-term debt | | (63,027) | | (69,914) | | 6,887 | | (62,622) | | (62,813) | | 191 | | Other liabilities | | (2,068) | | (3,125) | | 1,057 | | (661) | | (1,716) | | 1,055 | | | | | | | | | | | | | | | | Non-performing and non-interest-earning loans 2 | | 640 | | 3,493 | | (2,853) | | 708 | | 3,375 | | (2,667) | | 1 Primarily loans held-for-sale. | 2 Included in loans or other assets. | Gains and losses on financial instruments | | 2018 | | 2017 | | 2016 | |
in | | Net
gains/
(losses) | | Net
gains/
(losses) | | Net
gains/
(losses) | | Financial instruments (CHF million) | Interest-bearing deposits with banks | | 2 | 1 | 13 | 1 | 4 | 1 | of which related to credit risk | | (10) | | 0 | | 1 | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 2,451 | 1 | 2,206 | 1,4 | 1,440 | 1 | Other investments | | 241 | 3 | 215 | 2 | 214 | 2 | of which related to credit risk | | (1) | | (4) | | (3) | | Loans | | 717 | 1 | 1,542 | 1 | 1,643 | 1 | of which related to credit risk | | (296) | | 7 | | (16) | | Other assets | | 770 | 1 | 480 | 1 | (507) | 2 | of which related to credit risk | | 61 | | 96 | | (200) | | Due to banks and customer deposits | | (39) | 2 | 1 | 2 | (12) | 1 | of which related to credit risk | | (37) | | 5 | | (22) | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | (890) | 1 | (418) | 1,4 | (112) | 1 | Short-term borrowings | | 2,807 | 2 | (512) | 2 | 323 | 2 | of which related to credit risk | | (5) | | (23) | | (4) | | Long-term debt | | 4,375 | 2 | (6,615) | 2 | (1,136) | 2 | of which related to credit risk | | 7 | | (32) | | 22 | | Other liabilities | | 72 | 3 | 181 | 3 | 443 | 2 | of which related to credit risk | | 4 | | 88 | | 312 | | 1 Primarily recognized in net interest income. | 2 Primarily recognized in trading revenues. | 3 Primarily recognized in other revenues. | 4 Prior period has been corrected. | Gains/(losses) attributable to changes in instrument-specific credit risk on fair value option elected liabilities | |
Gains/(losses) recorded into AOCI | 1 | Gains/(losses) recorded
in AOCI transferred
to net income | 1 | in | | 2018 | | Cumulative | | 2017 | | 2018 | | 2017 | | Financial instruments (CHF million) | Deposits | | 36 | | (21) | | (15) | | (6) | | 0 | | Short-term borrowings | | 6 | | (53) | | (63) | | 2 | | 0 | | Long-term debt | | 1,520 | | (876) | | (1,768) | | 53 | | 32 | | of which treasury debt over two years | | 676 | | 132 | | (513) | | 0 | | 0 | | of which structured notes over two years | | 774 | | (1,060) | | (1,246) | | 53 | | 27 | | Total | | 1,562 | | (950) | | (1,846) | | 49 | | 32 | | 1 Amounts are reflected gross of tax. | Carrying value and fair value of financial instruments not carried at fair value | | Carrying
value | |
Fair value | | end of | | | | Level 1 | | Level 2 | | Level 3 | | Total | | 2018 (CHF million) | Financial assets | | | | | | | | | | | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 35,277 | | 0 | | 35,243 | | 35 | | 35,278 | | Loans | | 274,440 | | 0 | | 275,105 | | 7,047 | | 282,152 | | Other financial assets 1 | | 117,002 | | 99,238 | | 17,139 | | 796 | | 117,173 | | Financial liabilities | | | | | | | | | | | | Due to banks and deposits | | 376,741 | | 197,320 | | 179,448 | | 0 | | 376,768 | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | 9,795 | | 0 | | 9,795 | | 0 | | 9,795 | | Short-term borrowings | | 14,351 | | 0 | | 14,352 | | 0 | | 14,352 | | Long-term debt | | 90,406 | | 0 | | 89,707 | | 854 | | 90,561 | | Other financial liabilities 2 | | 16,803 | | 0 | | 16,547 | | 184 | | 16,731 | | 2017 (CHF million) | Financial assets | | | | | | | | | | | | Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions | | 37,848 | | 0 | | 37,848 | | 0 | | 37,848 | | Loans | | 264,181 | | 0 | | 268,380 | | 3,212 | | 271,592 | | Other financial assets 1,3 | | 170,687 | | 109,414 | | 60,518 | | 1,108 | | 171,040 | | Financial liabilities | | | | | | | | | | | | Due to banks and deposits | | 374,006 | | 202,164 | | 171,831 | | 0 | | 373,995 | | Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions | | 11,233 | | 0 | | 11,233 | | 0 | | 11,233 | | Short-term borrowings | | 15,359 | | 0 | | 15,359 | | 0 | | 15,359 | | Long-term debt | | 109,420 | | 0 | | 112,564 | | 235 | | 112,799 | | Other financial liabilities 2,3 | | 61,701 | | 0 | | 61,543 | | 146 | | 61,689 | | 1 Primarily includes cash and due from banks, interest-bearing deposits with banks, loans held-for-sale, cash collateral on derivative instruments, interest and fee receivables and non-marketable equity securities. | 2 Primarily includes cash collateral on derivative instruments and interest and fee payables. | 3 2017 balances included brokerage receivables and payables, which, effective January 1, 2018, were no longer included due to the adoption of ASU 2016-01. |
|